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CHAPTER 1 
According to the International Diabetes Federation ([IDF], 2014) about 387 million 
people worldwide have diabetes mellitus (DM). DM consists of type 1 diabetes mellitus 
(TlDM), type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM). For the 
most part, T 1 DM accounts for about 10% of all diabetics and T2DM accounts for the remaining 
90% (Canadian Diabetes Association [CDA], 2015; World Health Organization [WHO], 2015). 
Diabetes is a chronic condition that requires daily self-management to promote a healthy life. 
Unfortunately, the DM population is well known to be at risk for various complications 
associated with the chronic disease, including micorvascular and macrovascular complications 
(Jones, Brashers, & Huether, 2010). Another and less obvious complication that can arise from 
DM, is the risk for depression (CDA, 2013). The literature suggests that people with diabetes are 
twice as likely to develop depression compared to people without diabetes (Ali, Stone, Peters, 
Davies, & Khunti, 2006; Anderson, Clouse, Freedland, & Lustman, 2001). Furthermore, 
depression in adults with diabetes can have a negative impact on self-care (Egede, Ellis, & 
Grubaugh, 2009; Lin, Katon, Von Korff, et al., 2004; Lin, Katon, Rutter, et al., 2006; Lin, Von 
Korff, et al., 2012) resulting in poor patient outcomes related to diabetes complications and 
increased health care costs (CDA, 2009; Dufton, Li, & Koehoorn, 2007). Interventions aimed at 
depressed adults with diabetes and those at risk of developing depression may decrease the 
negative impact on self-care in this population and its detrimental consequences on the adult with 
diabetes. 
Primary care providers (PCPs) such as NPs provide care for patients with chronic 
conditions. The role of the NP involves providing comprehensive primary care, including but not 
limited to health promotion, history taking, risk assessment and screening of patients (College of 
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Registered Nurses of British Columbia [CRNBC], 2015a). Furthermore, NPs emphasis on health 
promotion along with longer appointment times (Horrocks, Anderson, & Salisbury, 2002) allows 
for the NP to complete a thorough investigation into the patient's ailments. In this regard, NPs 
caring for diabetic patients with depression have the opportunity and responsibility to assess for 
depressive symptoms (La Vance, Fairchild, & Rosado, 2015; Pearce, Pereira, & Davis, 2013). 
NPs can play a major role in managing patients with chronic conditions such as diabetes and 
depression by promoting self-care practices in this population. 
The purpose of this project is to review existing literature to answer the following 
question: 
How can the NP promote self-care for the patient with diabetes and depression? 
To address this question, the background literature will first be examined. This will 
include an overview of the pathophysiology and management of diabetes and depression, a 
description of self-care and relevant clinical guidelines. The role of the NP will be further 
explored. Following this, the methods and outcomes for this integrative literature review will be 
presented. By exploring the existing knowledge of NP promotion of self-care in this population, 
it will be possible to identify key interventions that can further highlight the vital role of the NP 
and primary care provider in the management of this vulnerable population. This in tum may 
lead to improved health care and patient outcomes. 
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Background and Context 
Diabetes mellitus has become a global threat; with 387 million people worldwide having 
diabetes and this number is expected to rise dramatically in coming decades (IDF, 2014). In 
2035, it is projected that the number of people with diabetes will rise to 592 million (IDF, 2014). 
As of 2014, there are approximately 2-3 million Canadians who suffer from diabetes (IDF, 2014; 
Statistics Canada, 2015) and it is estimated that the number will reach 3.7 million by 2018/2019 
(Public Health Agency of Canada [PHAC], 2011 ). In British Columbia alone, there are 216 172 
people with diabetes, 59% male and 41 % female (Statistics Canada, 2015). Furthermore, 
diabetes is the sixth leading cause of death in Canada (Statistics Canada, 2014). Additionally, 
Aboriginal populations in Canada are at increased risk of developing diabetes and diabetes 
related complications compared to non-Aboriginal Canadians (PHAC, 2011). Overall, diabetes is 
a serious and costly public health issue. Understanding the mechanisms to promote self-care, 
particularly in those with co-existing chronic conditions such as mental illness, is critically 
important in order to reduce health care costs and improve patient outcomes. The following 
section will present an overview of the pathophysiology, screening, diagnosis, and management 
of diabetes. 
Diabetes Mellitus 
Pathophysiology. According to Goldenberg and Punthakee (2013) "diabetes mellitus is a 
metabolic disorder characterized by the presence of hyperglycemia due to defective insulin 
secretion, defective insulin action or both" (p. S8). Diabetes consists of TlDM, T2DM and 
GDM, and for the most part TlDM accounts for about 10% of all diabetics, T2DM accounts for 
the remaining 90% and approximately 2-4% of all pregnancies are affected by GDM (CDA, 
2015; WHO, 2015). For the purpose of this paper, the term diabetes will be used to describe 
TlDM and T2DM, unless otherwise specified. 
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Type 1 diabetes mellitus. TlDM occurs when there is absolute insulin deficiency 
characterized by hyperglycemia. The pancreas is responsible for insulin secretion, specifically 
the beta cells. In the case of autoimmune-mediated diabetes, the beta cells are destroyed through 
immune mediated mechanisms. Once the beta cells are destroyed by 80-90%, hyperglycemia 
presents itself resulting in polydipsia, polyphagia, polyuria, weight loss and fatigue (Jones et al., 
2010). Genetic and environmental factors such as viral infections and bovine serum albumin are 
thought to be responsible for the autoimmune disorder (Jones et al., 2010). Nonimmune or 
idiopathic Tl DM does exist; however it is uncommon, occurring in people of African or Asian 
descent (Jones et al., 2010). Typically TlDM presents itself in childhood and at times in early 
adulthood. Clinical manifestations of Tl DM are abrupt in onset and as mentioned above consist 
of polyuria, polydipsia, polyphagia and weight loss. Initially, patients may present with diabetic 
ketoacidosis (DK.A) that is caused by hyperglycemia due to insulin deficiency and the production 
of ketone bodies ensues. Also, due to the loss of sodium by osmotic diuresis from glycosuria, 
lactic acidosis develops. DK.A requires prompt treatment as it can lead to coma and death. 
Type 2 diabetes mellitus. T2DM occurs when insulin resistance and inadequate insulin 
secretion by the beta cells coexist (Jones et al., 2010). Insulin resistance occurs when insulin-
sensitive tissues such as the liver, muscle, and adipose tissue have a poor response to insulin 
(Jones et al., 2010). To compensate, initially beta cells produce high levels of insulin called 
hyperinsulinemia. This stage can go on for years but eventually the beta cells become fatigued 
and beta-cell dysfunction ensues, causing insulin deficiency (Jones et al., 2010). Furthermore, it 
is believed that environmental and genetic factors play a role in the development of T2DM 
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including certain risk factors such as obesity and hypertension (Jones et al., 2010). An overview 
of risk factors for T2DM can be found in Table 1. T2DM typically occurs in adulthood however 
the chronic condition is starting to present itself in childhood. Clinical manifestations of T2DM 
are vague and can go unnoticed for many years as the beta cells try to compensate. However, 
patients may present with blurry vision, recurrent infections, signs of organ damage (kidney, eye, 
nerve and heart), and fatigue (Jones et al., 2010) 
Table 1 Risk Factors for Type 2 Diabetes Mellitus 
Risk factors for type 2 diabetes mellitus 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Age 2:40 years 
First-degree relative with type 2 diabetes 
Member of high-risk population (e.g. Aboriginal, African, Asian, Hispanic, or South 
Asian descent) 
History of prediabetes (IGT, IFG or AlC 6.0%-6.4%) 
History of gestational diabetes mellitus 
History of delivery of macrosomic infant 
Presence of end organ damage associated with diabetes: 
o Microvascular (retinopathy, neuropathy, nephropathy) 
o Macrovascular ( coronary, cerebrovascular, peripheral) 
Presence of vascular risk factors: 
o HDL cholesterol level <1.0 mmol/L in males, <1.3 mmol/L in females 
o Triglycerides 2: 1. 7 mmol/L 
o Hypertension 
o Overweight 
o Abdominal obesity 
Presence of associated disease: 
o Polycystic ovary syndrome 
o Acanthosis nigricans 
o Psychiatric disorders (bipolar disorder, depression, schizophrenia) 
o HIV infection 
o Obstructive sleep apnea 
Use of drugs associated with diabetes: 
o Glucocorticoids 
o Atypical antipsychotics 
o HAART 
Note. Abbreviations: Al C, glycated hemoglobin; FPG, fasting plasma glucose; HAART, highly 
active antiretroviral therapy; HDL, high-density lipoprotein; HIV, human immunodeficiency 
virus-1; IFG, impaired fasting glucose; !GT, impaired glucose tolerance 
(Adapted from Ekoe, Punthakee, Ransom, Prebtani, & Goldenberg, 2013) 
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Gestational diabetes mellitus. GDM occurs during pregnancy and increases the risk of 
the woman and child of developing T2DM later on in life (CDA, 2015). The pathophysiology of 
GDM is unclear, however "insulin resistance and inadequate insulin secretion are thought to be 
contributing factors" (Jones et al., 2010, p. 754). The same risk factors apply to GDM as T2DM 
and can be found in Table 1. 
Screening, diagnosis and management. In regards to screening, diagnosis and 
management of diabetes, international, national and provincial guidelines do exist (American 
Diabetes Association [ADA], 2015; BCGuidelines, 2015; CDA, 2013; IDF, 2012). For a 
comparison of the mentioned guidelines, please refer to Appendix A. For the purpose of this 
paper, the current CDA (2013) guidelines will be used, as they are the most commonly used 
guidelines in practice. Screening for TlDM is not recommended unless symptomatic and 
screening for T2DM is recommended every 3 years in individuals 2:40 years of age or in 
individuals at high risk for developing diabetes (Ekoe et al., 2013). A list ofrisk factors for 
T2DM can be found in Table 1. Individuals with the identified risk factors need to be rescreened 
more frequently (Ekoe et al., 2013). 
Diagnosis. The diagnostic criteria for diabetes are based on the CDA (2013) guidelines 
and can be found in Table 2. Once a diagnosis of diabetes is made, management options need to 
be implemented. 
Table 2 Diagnosis of Diabetes 
Test Result Dysglycemia 
Cate2ory 
FPG (mmol/L) 6.1-6.9 IFG 
No caloric intake for at least 8 hours 2:7.0 Diabetes 
AlC (%) 6.0-6.4 Prediabetes 
Using standardized, validated assay in the absence of factors that 
affect the accuracy of the A 1 C and not for suspected type 1 2:6.5 Diabetes 
diabetes 
7 
2hPG in a 75g OGTT (mmol/L) 7.8-11 IGT 
~11.1 Diabetes 
Random PG (mmol/L) ~11.1 Diabetes 
Any time of the day, without regard to the interval since the last 
meal 
Note. If asymptomatic, a repeat confirmatory test (FPG, AlC, or a 2hPG in a 75g OGTT must be 
done. If symptomatic, diagnosis made, and begin treatment. Abbreviations: 2hPG, 2-hour plasma 
glucose; Al C, glycated hemoglobin; FPG, fasting plasma glucose; FG, impaired fasting glucose; 
!GT, impaired glucose tolerance; OGTT, oral glucose tolerance test. 
(Adapted from Goldenberg & Punthakee, 2013) 
Management. The management of TlDM and T2DM has similarities and obvious 
differences. In regards to treatment of TlDM, insulin is the primary pharmacotherapeutic agent. 
There are different types of insulin used in the treatment of TlDM and they are organized based 
on the duration of their action. Insulin delivery systems consist of syringes, pens, and pumps 
(McGibbon, Richardson, Hernandez, & Doman, 2013). Patient education in the management of 
hypoglycaemia, SMBG, sick-days and lifestyle are imperative as part of the initial diagnosis and 
ongoing management ofTlDM and T2DM. Once the diagnosis ofT2DM is made and dependent 
on the A 1 C value and the patient preference, initiation of lifestyle modifications, the use of oral 
hypoglycemic agents, and/or insulin are warranted. Lifestyle modifications include changes in 
diet, weight loss and exercise, smoking cessation and can be trialled for 2-3 months to reduce 
AlC below 8.5%. Based on the AlC above 8.5%, lifestyle modifications and metformin are first 
line recommendations (Harper et al., 2013). For the patient with symptomatic hyperglycemia and 
metabolic decompensation, insulin and/or metformin are initiated (Harper et al., 2013). Oral 
hypoglycemic agents can be found in Table 3. AlC target should be achieved within 3 to 6 
months of initiating therapy (Harper et al., 2013). DM is a chronic condition that requires 
continuing self-management by the patient based on the education and guidance provided by a 
health care provider. 
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Table 3 Types of Oral Hypoglycemic Agents 
Drug Type Mechanism of Action 
a -Glycosidase inhibitor Delays carbohydrate absorption in gut by inhibiting 
disaccharides 
Biguandie (metformin) Decreases hepatic glucose production 
Increases insulin sensitivity and peripheral glucose 
uptake 
Meglitinides (glinides) Stimulate insulin release from pancreatic beta cells 
Amino acid derivatives Stimulates insulin release from pancreatic beta cells 
Sulfonylureas Stimulates insulin release from pancreatic beta cells 
Thiazolidinediones Increase insulin sensitivity, particularly in adipose 
tissue 
DPP-IV inhibitors Increase GLP-1 levels which promotes insulin secretion 
(DPP-IV: Dipeptidyl peptidase-IV) (GLP-1: glucagon-like peptide 1) 
(Adapted from Jones et al., 2010) 
Caring for the patient with diabetes. Health care providers involved in the management 
of diabetes include but are not limited to endocrinologists, general practitioners (GPs), NPs, 
registered nurses (RNs), social workers, dieticians, and or diabetes educators (DEs). The 
management of diabetes is largely carried out in the primary care setting and as with any chronic 
condition, at times referral is warranted. In regards to diabetes, it is a referral to an 
endocrinologist and this is also true in regards to TlDM (:'.Sl 8yo ). Diabetes clinics do exist and 
are composed of a mix of the above-mentioned health care providers. However, diabetes clinics 
are typically located in large urban centres and are not as abundant in the rural setting. Given the 
geographical layout of BC, the management of diabetes is mainly provided in the primary care 
setting by a GP, NP or DE. NPs can provide the diabetic patient with individualized patient 
centered care, including self-management, medication adjustments, and lifestyle choices. 
Furthermore, NPs have been shown to reduce AlC levels, reach target BPs, reduce LDL levels 
and improve self-efficacy among T2DM patients who had uncontrolled hyperglycemia 
(Richardson, Derouin, Vorderstrasse, Hipkens & Thompson, 2014). As such, NPs can have a 
positive impact on patient outcomes. 
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Diabetes is a chronic condition that requires self-management, medication adherence, 
lifestyle modifications and oversight by a health care provider to prevent complications. Self-
care activities such as SMBG, a healthy diet, regular exercise, foot care and adherence to 
medication treatment are the reality of living with diabetes. The diagnosis and daily management 
of diabetes can be overwhelming and can have a negative impact on a patient ' s well-being and 
quality oflife (Egede, Grubaugh, & Ellis, 2010; Whiting, Scammel, Gray, Schepers, & Bifulco, 
2006). Additionally, when patients with diabetes do not adhere to the above mentioned self-care 
activities, they place themselves at greater risk of complications. The next section will speak to 
diabetes related complications. 
Complications. Regardless of the type of diabetes, the given population is well known to 
be at risk for complications. Micorvascular complications arise due to damage to small blood 
vessels and are responsible for retinopathy, nephropathy and neuropathy, contributing to the 
leading cause of blindness, chronic kidney disease, and nerve damage (CDA, 2015 ; Fowler, 
2008; Jones et al. , 2010). Macrovascular complications stem from damage to large blood vessels 
and consist of coronary artery disease (CAD), stroke and peripheral arterial disease, leading to 
problems such as myocardial infraction (MI), stroke, foot problems, and amputations (CDA, 
2015; Fowler, 2008; Jones et al. , 2010). Macrovascular complications are the leading cause of 
mortality among the diabetic population (PHAC, 2011). Furthermore, cardiovascular related 
complications such as MI or stroke are significantly higher among diabetics compared to those 
without the disease (Poirier, Dufour, Carpentier, & Larose, 2013). Even more worrisome is the 
179 million of individuals with diabetes who go undiagnosed (IDF, 2014). As macrovascular 
changes start to happen when hyperglycemia persists and in the case of cardiovascular 
complications the risk is present well before the diagnosis of diabetes is made (PHAC, 2011 ). 
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Again, this leads to increased health care costs and poor patient outcomes. As such, it is 
imperative to have a timely diagnosis and management plan in order to halt and or prevent these 
adverse outcomes. Additionally, due to the daily demands of living with diabetes, to no surprise 
this population is at risk of comorbid depression (Ali et al. , 2006; Anderson et al. , 2001 ). The 
next section will speak to depression in diabetes. 
Diabetes and Depression 
Depression in diabetes, coined by Ciechanowski (2011) as "diapression", is associated 
with adverse outcomes in this population. Interestingly enough a meta-analysis by Anderson et 
al. (2001) found that people with diabetes are twice as likely to develop depression compared to 
people without diabetes and in another meta analysis, Ali et al. (2006) found that the prevalence 
of depression was higher among type 2 diabetics compared to those without the condition (17.6 
vs. 9.8%, OR=l.6, 95%, CI 1.2-2.0). Furthermore, the literature demonstrates that self-care 
activities such as SMBG, healthy diet, regular exercise, foot care, and medication adherence are 
impaired in diabetics with depression (Egede et al. , 2009; Gonzales et al. , 2008 ; Lin, Katon, Von 
Korff, et al., 2004; Lin, Katon, Rutter, et al., 2006; Lin, Von Korff, et al. , 2012; Sumlin et al., 
2014). This further escalates the morbidity and mortality associated with "diapression" compared 
to the general population (Egede & Ellis, 2010; Katon et al., 2005) and, to no surprise, this places 
a great burden on our health care services. In a Canadian cross sectional study, Dufton et al. 
(2007) discovered that diabetics with depression utilized more health care dollars compared to 
those with diabetes only. These studies are suggestive that depression plays an adverse role in 
diabetes care. 
Similarly, depression has been linked to other chronic conditions including heart disease, 
cancer, chronic pain, HIV/AIDS, osteoporosis, Parkinson's disease and stroke (National Institute 
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of Mental Health, n.d.). In particular, patients with heart disease including acute myocardial 
infraction (AMI) survivors (Thombs et al., 2006) and heart failure (HF) patients (Lossnitzer et 
al., 2013; Rutledge, Reis, Linke, Greenberg, & Mills, 2006) have been found to have a higher 
risk of developing depression. Regardless of the chronic condition, depression has the potential 
for poor patient outcomes and this is true in regards to diabetes. Existing guidelines recommend 
screening for mental health disorders, specifically depression among the diabetic population 
(BCGuidelines, 2015; CDA, 2013; IDF, 2012). However, none of the guidelines address how 
often to screen for depression in patients with co-existing chronic diabetic disease. Given that the 
majority of patients with diabetes are treated by PCPs, regular diabetes follow-up appointments 
may be the optimal time to screen patients for depressive symptoms. Additionally, prompt 
recognition and treatment of depression may improve not only depressive symptoms but also 
diabetes related self-care. The following section will provide an overview of depression. 
Depression 
Diagnosis. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-V; American Psychiatric Association [APA], 2013) defines the diagnostic criteria for 
major depressive disorder (MDD) as: 
Five (or more) of the following symptoms have been present during the same 2-week 
period and represent a change from previous functioning; at least one of the symptoms is 
either (1) depressed mood or (2) loss of interest or pleasure. 
1. Depressed mood most of the day, nearly every day, as indicated by either subjective 
report (e.g. feels sad, empty hopeless) or observation made by others (e.g. appearance 
tearful). 
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2. Markedly diminished interest or pleasure in all, or most all, activities most of the day, 
nearly every day (as indicated by either subjective account or observation). 
3. Significant weight loss when not dieting or weight gain (e.g. a change of more than 5% 
of body weight in a month), or decrease or increase in appetite nearly every day, 
4. Insomnia or hypersomnia nearly everyday. 
5. Psychomotor agitation or retardation nearly every day (observable by others, not 
merely subjective feelings of restlessness or being slowed down). 
6. Fatigue or loss of energy nearly every day. 
7. Feelings of worthlessness or excessive or inappropriate guilt (which may be 
delusional) nearly everyday (not merely self-reproach or guilt about being sick). 
8. Diminished ability to think or concentrate, or indecisiveness, nearly ever day ( either by 
subjective account or as observed by others). 
9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without 
a specific plan, or a suicide attempt or a specific plan for committing suicide (p.160) 
Risk factors. There are several risk factors associated with the development of MDD. 
According to the APA (2013) risk factors are temperamental, environmental, genetic and 
physiological, and course modifiers. Temperamental risk factors consist of neuroticism, which is 
a proclivity to respond to numerous life situations with negative emotions (APA, 2013). 
Environmental risk factors include stressful life events and unfavourable childhood experiences 
such as emotional abuse, emotional and physical neglect (APA, 2013 ; Bailer et al. 2014). 
Genetic and physiological risk factors comprise a first-degree relative with MDD which, 
compared to the general population, increases the risk ofMDD two to four times (APA, 2013). 
Course modifiers are attributable to nonmood disorders, such as substance use and anxiety. 
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Certain chronic conditions increase the risk of developing MDD such as cardiovascular disease, 
cancer, and diabetes (APA, 2013). In regards to diabetes, there is an abundance ofliterature 
demonstrating the association between diabetes and depression (Bell et al., 2010; Dirmaier et al., 
2010; Egede et al., 2009; Lin et al., 2004). Furthermore, diabetes and depression appear to have a 
bidirectional relationship and there is ongoing research trying to identify which condition comes 
first, diabetes or depression. Additionally, some patients with diabetes view the diagnosis as a 
life-threating event (Whiting et al., 2006). 
Screening. Screening for depression is an integral part of providing primary care. During 
a comprehensive assessment, the NP or PCP may use various assessment tools to screen for 
depressive symptoms and the Patient Health Questionnaire (PHQ-9) is a well-validated tool 
(Kroenke, Spitzer, & Williams, 2001). The PHQ-9 is a self-reported assessment tool, which 
consists of nine questions based on the DSM-V criteria for MDD. Often enough, asking the first 
two questions of the PHQ-9 referred to as PHQ-2, is an effective way to screen for MDD (Arroll 
et al., 2010; Kroenke et al., 2001). An answer of yes to either question warrants further 
investigation. The PHQ-9 is scored and categorized accordingly for depression severity: minimal 
depression (1-4), mild depression (5-9), moderate depression (10-14), moderately severe 
depression (15-19) and severe depression (20-27) (Kroenke et al., 2001 ). The PHQ-9 is not a 
diagnostic tool, but rather a tool to guide the PCP in determining the presence of MDD. 
Furthermore, suicide risk is addressed by the PHQ-9 and needs to be assessed with any 
depressive episode. Refer to Appendix B for the PHQ-9 screening tool. 
Management. The management ofMDD is based on the 2009 Canadian Network for 
Mood and Anxiety Treatments (CANMAT) clinical guidelines. The literature demonstrates that 
the combination of non-pharmacological and pharmacological options is best for the first-line 
treatment of MDD depending on the presenting acuity (Parikh et al., 2009). 
14 
Non-pharmacological options. Non-pharmacological options for MDD consist of 
psychotherapies. The two types of psychotherapies that have been identified in the literature are 
Cognitive Behavioural Therapy (CBT) and Interpersonal Therapy (IP), and both are 
recommended as first-line treatment for acute MDD (Parikh et al., 2009). Furthermore, both 
psychotherapies are recommended for the maintenance of improvement among patients with a 
diagnosis ofMDD (Parikh et al., 2009). PCPs are able to perform CBT in practice, however 
referral and consultation with a clinical counselor, psychologist and or psychiatrist may be 
warranted. 
Pharmacological options. The recommended pharmacological options for the 
management of moderate to severe MDD are antidepressants. The pharmacological options are 
further categorized as first-line, second-line and third-line. First-line antidepressants consist of 
bupropion, citalopram, devenlafaxine, duloxetine, escitalopram, fluoxetine, fluvoxamine, 
milnacipran, mirtazapine, moclobemide, parozetine, reboxetine, sertraline, tianeptine and 
venlafaxine. Second-line agents include amitriptyline, clomipramine and other tricyclic 
antidepressants, quetiapine, selegiline, and trazadone. Lastly, third-line options are phenelzine 
and tranylcypromine (Lam et al., 2009). Pharmacological treatment of MDD requires 2 weeks in 
duration to achieve minimum therapeutic dose, and at times requiring a dose increase over 4-6 
weeks (Lam et al., 2009). First-line antidepressants are recommended as initial therapy for 
MDD. At times, patients do not respond to the prescribed antidepressant and it is suggested to 
switch to another first-line medication on the list. 
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As demonstrated, the management of both depression and diabetes is complex and may 
require the use of a wide range of interventions and therapies, including multiple drug therapies. 
Furthermore, when combined, depression can adversely impact upon an individual's ability to 
effectively manage their diabetes, specifically in performing diabetes self-care activities, thus 
leading to greater risk of poor health outcomes and adverse events. Self-care is a major 
component of minimizing these adverse events and optimizing healthcare outcomes. The 
following section will provide a brief overview of self-care and its relation to diabetes and 
depression. 
Self-care 
Self-care is an integral part of managing any chronic condition and requires the patient 
and PCP to work in collaboration. The importance of self-care has been described in the 
literature regarding chronic conditions including DM and HF (Ades et al., 2013; Egede et al., 
2009). Each chronic condition has its own self-care activities that the patient should adhere to in 
order to prevent or reduce complications associated with the given condition. The choice of 
treatment lies with the patient; however the support needs to be present from the PCP. In 2002, 
Supporting Self-Care: A Shared Initiative 1999-2002 report was published in conjunction with 
Health Canada, the Canadian Nurses Association (CNA), the College of Family Physicians of 
Canada, Canadian Association of University Schools of Nursing and the Association of 
Canadian Medical Colleges. This collaborative report emphasized the need to support self-care 
in the primary health care setting and utilized the definition of self-care provided by Dean (1986; 
as cited in CNA, 2002, p.17): 
Self-care involves the range of activities individuals undertake to enhance health, prevent 
disease, evaluate symptoms and restore health. These activities are undertaken by lay 
people on their own behalf, either separately or in participation with professionals. Self-
care includes decisions to do nothing, self-determined actions to promote health or treat 
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illness, and decisions to seek advice in lay, professional and alternative care networks, as 
well as evaluation of and decisions regarding action based on that advice. (p. 62) 
This definition of self-care highlights the patient as being in charge of their actions and I believe 
it relates well to the management of diabetes. For the purpose of this paper, self-care activities in 
the diabetic patient consist of SMBG, a healthy diet, regular exercise, foot care and adherence to 
medication treatment. Furthermore, for those patients with depression self-care behaviours can 
improve medication adherence and promote better health outcomes overall (Bogner, Morales, 
Post and Bruce, 2007; Bogner, Morales, de Vries and Cappola, 2012; Johnson et al., 2014; Katon 
et al., 2010). The literature suggests a need to better understand the relationship between 
depression in diabetes and its effect of self-care activities as depression in diabetes has shown 
adverse outcomes associated with poor glycemic control (hemoglobin AlC ~7), medication 
adherence and self-care routines (Egede et al., 2009; Gonzales et al. , 2008; Lin, Katon, Von 
Korff, et al., 2004; Lin, Katon, Rutter, et al. , 2006; Lin, Von Korff, et al., 2012). In order for 
patients with diabetes to engage in self-care activities, they require the knowledge, physical skills 
and emotional capacity to make informed choices regarding their health (Siguroardottir, 2005). 
NPs are PCPs that can support self-care in the diabetic with depression (La Vance et al., 2015; 
Richardson et al. , 2014). 
Nurse Practitioner 
The role of the NP is a relatively new profession in Canada and in BC, NPs have been 
regulated since 2005 (CRNBC, 2015b). In BC, NPs are advanced practice nurses who are 
educated at the Master's level and are able to diagnose, prescribe medication, and order 
diagnostic testing within their scope of practice (CRNBC, 2015a). Furthermore, the CNA (2010) 
elaborates that: 
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Nurse practitioners integrate their in-depth knowledge of advanced nursing practice and 
theory, health management, health promotion, disease/injury prevention, and other 
relevant biomedical and psychosocial theories to provide comprehensive health services. 
Nurse practitioners work in collaboration with their clients and other health-care 
providers in the provision of high-quality patient-centered care. They work with diverse 
client populations in a variety of contexts and practice settings. (p.5) 
Given the nature of the NP role, the NP is well situated to support self-care in the context of 
chronic disease management. According to the CRNBC (2015a), diabetes and depression are 
conditions that the NP is able to diagnose and manage independently. The NP caring for diabetic 
patients who suffer from depression has the opportunity to screen and identify the diabetic 
patients at risk of developing depression and monitor patients who already suffer from 
depression (La Vance et al., 2015; Pearce et al., 2013; Richardson et al., 2014). Self-care 
activities are reflective of AlC control and Richardson et al. (2014) found that NPs in 
collaborative practice with PCPs have been shown to reduce AlC levels, reach target BPs, 
reduce LDL levels and improve self-efficacy among T2DM patients who had uncontrolled 
hyperglycemia. 
The NP can provide individualized patient centered care and management depending on 
the presentation of the patient including self-management, medication adjustments, and lifestyle 
choices. In the primary health care setting, the NP role has some overlap with the GP and a 
Cochrane review found that NPs in the primary health care setting have similar health outcomes 
compared to GPs (Reeves, Hermens, Braspenning, Grol, & Sibbald, 2005). Furthermore, patient 
satisfaction was reported higher for NPs compared to GPs and this can be attributed to the health 
advice and time a NP spends with the patient (Harrocks et al., 2002; Reeves et al., 2005). In a 
recent comparison of primary care provided by NPs versus GPs, Kuo, Chen, Baillargeon, Raji 
and Goodwin (2015) found no significant difference in preventable hospitalizations for patients 
with diabetes. Again, these findings demonstrate that NPs provide comparable care to GPs and 
are competent primary care providers. 
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Diabetes is a global threat. The prevalence of depression is higher among those with 
diabetes and the presence of depression in diabetics is associated with an increase in mortality 
rates. I believe it is imperative to support the above-mentioned population, specifically in 
relation to self-care activities as a decline in these activities can have negative health outcomes. 
This population poses a challenge for the primary health care setting and this integrative 
literature review will respond to the following question: 
How can the NP promote self-care for the patient with diabetes and depression? 
The next chapter will present the literature review search strategy and results. 
CHAPTER2 
Methods 
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The aim of this integrative literature review is to answer the following question: How can 
the NP promote self-care for the patient with diabetes and depression? Understanding the 
relationship between diabetes and depression, along with examining effective strategies to 
promote self-care has the potential to improve both healthcare and patient outcomes. The 
following section will provide an overview of the literature review methods and analysis 
strategies. 
This integrative review of the literature consisted of quantitative and qualitative research. 
The integrative approach allowed for a comprehensive representation of the data available about 
diabetes and depression in the primary care setting. This approach is inline with Whittemore and 
Knalfs (2005) proposed strategies to enhance rigour in conducting an integrative review. 
Performing a rigorous integrative review allows for synthesis of available literature on a given 
healthcare topic which in turn can inform clinical practice and evidence-based practice 
(Whittemore and Knalf, 2005). 
Development of the Search Strategy 
To answer the question, a comprehensive search and analysis of the current literature was 
undertaken. First, I used the following databases to identify and search the relevant body of 
literature. Databases included: Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) complete, PubMed, Psychlnfo, Cochrane Reviews, and the Joanna Briggs Institute 
library. A hand search ofreference lists of key articles was also undertaken to ensure that all 
potential sources of literature were identified. To ensure that the appropriate literature was 
captured, a broad list of search terms and keywords were used. These are summarized in Table 4. 
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Table 4 Search Terms and Keywords 
Diabetes Depressive Exercise Primary health care 
symptoms 
Diabetes mellitus Self-care Healthy diet Family physicians 
Diabetes mellitus type 1 Self-management Blood glucose self- Family nurse 
monitoring practitioners 
Diabetes mellitus type 2 Self-efficacy Medication Adult nurse 
compliance practitioners 
Depression HAie Health screening Nurse Practitioners 
Major depression Glycemic control Foot care 
Minor depression Physical activity Nutrition 
Additionally, the Health Sciences Librarian at the University of Northern British Columbia 
(UNBC) was consulted on three separate occasions to ensure that the search was comprehensive. 
Grey literature was also valuable for information relevant to the review including guidelines and 
recommendations from the CDA, IDF, PHAC, and WHO. 
Eligibility Criteria 
To be eligible for inclusion in the review, articles were screened to ensure that they met 
the inclusion and exclusion criteria. The criteria were developed to ensure that the review 
remained focused on the research question and that only research relevant to the Canadian 
context was captured in order to inform practice. The inclusion criteria included: 
1) Adults (~18 years of age) with TIDM or T2DM. 
2) Primary care providers (GPs and NPs). 
3) Primary care setting. 
4) Depression. 
5) Self-care activities relevant to diabetes. 
Included studies were peer-reviewed and dated from 2004-2015. The reason for including studies 
dating back 11 years was to capture the evolution of the literature specific to depression in 
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diabetics. Included studies had to be published in English and include human subjects. To ensure 
that only relevant literature was captured, articles dated before 2004, not in English language and 
were focused upon other types of diabetes (GDM or diabetes insipidus) were excluded. 
Screening and Review of the Literature 
The preliminary search of the literature yielded a total of 185 articles. Once duplicates 
were removed, this resulted in an initial group of 171 articles. Following a review of titles and 
abstracts, this was further reduced to 41 articles. At this time, a hand search was undertaken with 
an additional 17 results for a total of 58 sources. Of these sources, 11 were excluded, as they did 
not meet the inclusion criteria. At this time, it was felt that data saturation was met as duplicates 
were found in multiple sources. For a thorough appraisal of the literature, each study was 
individually appraised using the Critical Appraisal Skills Programme tools ([CASP], 2013). 
Following this, studies were analysed in light of the literature review question: How can NPs 
support self-care for patients with diabetes and depression? Of the 4 7 studies reviewed, 18 
pertained to this literature review and the remaining studies were utilized in the background 
section, see Appendix C for the literature search strategy flowchart. After critical analysis of the 
literature, three themes became evident and these are: 
1) The effect of depression on diabetes self-care. 
2) Intervention for patients with diabetes and depression. 
3) Patient perception of care. 
The following chapter will provide a critical overview of the findings of this integrative 
literature. 
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CHAPTER3 
Findings 
This integrative review explores how the NP can support self-care for the patient with 
diabetes and depression in primary care. A final cohort of 18 publications was identified and 
analysed. Following a critical analysis of the literature three themes were identified. These are 1) 
the effect of depression on diabetes self-care, 2) interventions for patients with diabetes and 
depression, and 3) patient perception of care. 
The Effect of Depression on Diabetes Self-Care 
The effect of depression on diabetes self-care was a key theme that emerged from the 
analysis of the literature. Five studies were identified that focused upon depression among 
diabetic patients. Key findings included the negative impact of depression upon self-care 
activities, medication nonadherence and the quality of care received by these patients. 
Lin et al. (2004) conducted a cross-sectional study, which examined the relationship 
between depression and diabetes self-care, medication adherence and preventative care among 
adults with diabetes in Washington State. Participants were recruited from the Group Health 
Cooperative (GHC), which is a prepaid health plan and nine primary care clinics, and were asked 
to complete a questionnaire. About 450,000 patients with diabetes were mailed the Diabetes 
Self-Care Activities (SDSCA) scale and the PHQ-9 questionnaires and participants were 
provided with a with a $3.00 gift certificate. Furthermore, medication adherence was measured 
using prescription refill data for oral hypoglycemic agents, antihypertensive agents, and lipid-
lowering agents (Lin et al., 2004). A total response rate of 62% was achieved with a total sample 
size of 4 463 participants. 
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The clinical and demographic characteristics of the study population identified that the 
sample was 51.3% male, with a mean age of 63.3 ±13.4 years, 95 .6% had type 2 diabetes, 59% 
were taking oral hypoglycemic agents, and had a mean AIC of 7.8 ±1.6% (Lin et al. , 2004). 
Self-care activities were infrequently reported among the whole sample. Medication 
nonadherence was common for patients on oral hypoglycemic agents, on average patients missed 
64. 7 ± 71.1 days during the previous year (Lin et al. , 2004). Additionally, Lin et al. found that 
clinical monitoring of diabetes using Al C levels (2 .2 tests/year) and checking for 
microalbuminuria (50% of patients/year) were not in accordance with the recommendations by 
the American Diabetes Association (ADA). While the majority of participants were not managed 
to the clinical guidelines, 90% of the study sample did report having a retinal exam within the 
previous year. Depression was found among 12% of the patients, with more females being 
affected (14.4%) compared to males (9.8%). In their analysis, diabetes self-care activities were 
notably worse for patients with depression compared to non-depressed patients, specifically fruit 
and vegetable intake (32.4 vs. 21.1 %) and fat intake (15.5 vs. 11.9%). For example, depressed 
patients in this cohort were less likely to exercise and twice as likely to smoke (Lin et al., 2004). 
No significant differences were noted for SMBG and self foot exams. Medication nonadherence 
was higher among depressed patients for all three classes, and on average patients missed 80 
days of taking oral hypoglycemic agents (Lin et al., 2004). 
This study provides a solid overview of the key issues relating to self-care management 
in patients with diabetes and depression; however, a number of limitations exist. Limitations of 
the study by Lin et al. (2004) include its cross-sectional design, possible overestimation of self-
reported self-care activities and the use of prescription refill data to assess medication 
nonadherence. Despite these limitations, Lin et al. highlight the relationship between diabetes 
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and depression, and specifically the effect of depression on self-care activities and medication 
nonadherence. Furthermore, strengths of the study are the large sample size and high response 
rate. Additionally, this study highlights that guideline recommendations are not always followed 
in practice. 
Similar findings were identified in a cross-sectional study by Bell, Andrews, Arcury, 
Snively, Golden and Quandt (2010). This study examined the association of depressive 
symptoms with diabetes self-management among rural older adults (~65) with T2DM. Data was 
obtained from the Evaluating Long-term Diabetes Self-management Among Elder Rural Adults 
(ELDER) Study. A sample of 696 participants was selected from two largely rural counties in 
North Carolina, with an 89% response rate. Face-to face interviews were conducted and data was 
recorded on paper forms. To measure outcomes, the study utilized the summary of diabetes self-
care activities (SDSCA) scale using five domains. Depressive symptoms were measured using 
the Center for Epidemiologic Studies depression (CES-D) scale. Quality of life was measured 
using the physical (PCS) subscale of the SF-12 healthy survey, a short form survey which 
consists of 12 questions to measure functional health with a higher score indicating higher 
physical functioning. Data were analysed using the SAS Statistical Software and patient 
demographics, health characteristics and self-management outcomes, were categorized by CES-
D score (Bell et al., 2010). 
In regards to ethnicity, the sample consisted of 31.6% African Americans, 26% American 
Indian and 42.4% Caucasians, with a mean age of74.1±5.6, 15.8% had CES-D ~9 and 84.2% 
had a CES-D <9. Bivariate associations between demographic and health characteristics and 
CES-D were evaluated for statistical significance using chi-square or independent sample t-tests 
(Bell et al., 2010). Demographic characteristics revealed that depressive symptoms (CES-D ~9) 
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were associated with being female (P <0.001), not being married, lower socioeconomic status 
and lower level of education. Furthermore, Bell et al. found that depressive symptoms were 
associated with certain health characteristics including fair or poor self-rated health, lower 
physical activity (odds ratio= 0.5, 95% CI, 0.2-0.9), lower healthy eating habits, higher number 
of medications and chronic conditions. No significant differences were noted in regards to 
SMBG and medication adherence between high and low depressive symptoms. Interestingly, a 
high CES-D score was associated with higher rates of self-foot exams ( odds ratio = 2 .1, 95% CI, 
1.1-3.9). Conversely, Lin et al. (2004) found no significant difference between depressed and 
nondepressed patients in regard to self-foot checks and frequency of SMBG. 
Limitations of the study by Bell et al. (2010) include its cross-sectional design, as it is 
unable to assess the cause and effect relationship between diabetes and depression. Furthermore, 
depression was not associated with poor glycemic control, as previously seen in earlier studies. 
Despite these limitations, this study adds a large, ethnically diverse population with a high 
response rate. Additionally, this study highlights that certain self-management activities were 
poorly associated with higher depressive symptoms, suggesting that depression may be a barrier 
in itself to performing self-care activities such as physical activity and eating well. Lastly, this 
study adds that regardless of age, patients with diabetes should be screened for depressive 
symptoms. 
Dirmaier et al. (2010) conducted a prospective-longitudinal study, which examined the 
relationship between depression, diabetes, nonadherence and glycemic control among adults in a 
nationally representative sample in Germany over 12 months. Dirmaier et al. analysed data from 
the Diabetes Cardiovascular Risk Evaluation: Targets and Essential Data for Commitment of 
Treatment (DETECT) study. Depression was assessed using the Depression Screening 
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Questionnaire (DSQ). Medication adherence was assessed using patient response to "How often 
did you have problems taking your medications prescribed by your physician?" (Dirrnaier et al., 
2010, p.173) using a 4 level response (almost never/rarely/often/always) in the past 4 weeks. 
The patient's physician reported the diagnosis of diabetes and satisfactory glycemic control was 
measured using an AlC (<7%) versus unsatisfactory glycemic control (2:7%). Statistical data 
analysis was done using x2 or t tests for differences between T2DM patients and level of 
depression (Dirrnaier et al. , 2010). Additionally, in light of depression status, logistic regression 
was used to analyse medication adherence and glycemic control, and linear regression was used 
to analyse problems with health behaviour (Dirrnaier et al., 2010). 
The final sample consisted of 866 participants and of these, 20. 7% were found to have 
subthreshold depression (DSQ 5-7) and 11. 7% of participants had depression (DSQ > 7). Results 
of the Dirrnaier et al. (2010) study found 49% of the sample to be female with a mean age of 65. 
Dirrnaier et al. found that having subthreshold depression or depression at baseline was 
associated with problems with diabetes-related behaviour at follow-up. Additionally, baseline 
depression was associated with medication nonadherence at follow-up, as was poor glycemic 
control (OR= 2.01; CI: 1.10-3.69; p = 0.023). Interestingly, after adjusting for gender, age, 
marital and employment status, education, physical activity, BMI, smoking, duration of diabetes, 
and type of diabetes treatment, baseline medication nonadherence (p = 0.07) and poor diabetes-
related behaviour (p = 0.18) was not associated with poor glycemic control at follow-up. 
Limitations of the Dirrnaier et al. (2010) study include use of self-reported data on 
medication adherence, using only one item to assess medication adherence and not assessing 
diabetic self-care activities. Despite these limitations, the study does have a few strengths. The 
study is representative of a national cohort of primary care patients in Germany and the findings 
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are relevant to the Canadian context. Additionally, due to its prospective study design it suggests 
a causal relationship between diabetes and depression. Also, the study used multiple sources for 
data collection including patient and physician questionnaires. 
The last study in this section is a cross-sectional study by Egede, Ellis and Grubaugh 
(2009) that examined the effect of both minor and major depression on self-care behaviours and 
quality of care among adults with diabetes. Participants were recruited from the 2006 Behavioral 
Risk Factor Surveillance System (BRFSS) survey, which is a national telephone survey using 
random digit dialling, identifying a sample of 351,968 adults. In this sample, 28,438 participants 
had diabetes resulting in a final sample of 16,754 of participants who had completed a PHQ-8 to 
assess depression status (0-4: no depression, 5-9: minor depression, 2'.:10: major depression). The 
PHQ-8 in comparison to the PHQ-9 omits the suicide question. 
The results within the Egede et al. (2009) study found 65.5% of participants had no 
depression, 19.7% had minor depression and 14.7% had major depression. Significant 
differences were found between the three groups concerning race, sex, age, education, income, 
marital status, employment status, perceived health status and insurance. Major depression was 
associated with being female (61.64%), having less than a high school diploma (29.17%), having 
an income of less than 25,000 (63.9%), being married (49.65%), being employed (20.81%) and a 
perceived health status as "fair/poor" (79.58%). Surprisingly, no significant differences were 
found in regards to having a health care provider or diabetes education. In regards to self-care 
behaviours, major depression was associated with decreased exercise, current smoking status and 
lower SMBG. No significant differences were noted among the three groups in regards to home 
foot exams. In regards to quality of care Egede et al. found differences in the three groups in 
regards to frequency of a provider foot exam, frequency of a dilated eye exam and having a flu 
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shot in the past 12 months. No significant differences were found between groups for physician 
appointments and frequency of A 1 C testing. 
The limitations of the Egede et al. (2009) study include its use of a telephone survey, as 
the potential of households without telephones exists. Additionally, the BRFSS has the potential 
for recall bias. Also, the gold standard for the diagnosis of depression is a psychiatric interview, 
however the PHQ-8 is a well-validated tool used in the primary care setting. Lastly, the study is 
limited by its cross-sectional design. Despite these limitations, Egede et al. highlighted the 
demographic characteristics associated with major depression and diabetes. Additionally, Egede 
et al. found that the recommended guidelines were less likely to be followed in the depressed 
participants, as the frequency of eye exams and flu shots were lower in this group. Egede et al. 
suggest that this may be due to different treatment of depressed patients versus non-depressed 
patients and that these patients may be less likely to comply with the recommended scheduled 
appointments. Furthermore, Egede, Grubaugh and Ellis (2010) conducted a follow-up study 
addressing the effect of depression on preventative care and quality of care among patients with 
diabetes. Egede et al. (2010) found that the presence of depression was associated with a 
decrease in females receiving guideline care for breast screening. These findings suggest that this 
population does not always receive disease specific and or preventative care as recommended by 
guidelines. 
In summary, the effect of depression on diabetes analysed within this section 
demonstrates the negative association between the two conditions and their effect on self-care, 
medication nonadherence and quality of care received by these patients. The evidence 
demonstrates that certain subgroups are at greater risk of developing depression such as being a 
woman, those with lower education and socioeconomic status, and longer duration of diabetes. 
These studies provide valuable evidence supporting the need to screen and identify diabetic 
patients at risk of developing comorbid depression. 
Interventions for Patients with Diabetes and Depression 
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The integrative review of the literature revealed that there were a number of interventions 
that can be used in this patient population. Nine studies based on the interventions used to 
support the diabetic patient with depression were identified and will now be presented. This 
section is subdivided into three sections: enhanced depression treatment, integrated management 
of diabetes and depression, and patient centred collaborative care for multimorbidities. 
Enhanced depression treatment. Lin et al. (2006) conducted a randomized control trial 
that examined the effect of enhanced depression treatment on diabetes self-care. Patients were 
recruited from 9 primary care clinics of Group Health Cooperative (GHC) in Washington State. 
A questionnaire was sent out to 7, 841 patients, with a 62% response rate. To be eligible for the 
study, patients had to have a PHQ-9 2:10 and demonstrate on going depressive symptoms. This 
yielded 375 patients, with 46 declining to participate. Of the 329 patients, 164 were randomized 
to intervention and 165 to usual care. The intervention consisted of a nurse care manger who 
offered patients an initial choice of two evidence-based treatments: antidepressant medication or 
problem-solving treatment (Lin et al. , 2006). Medication adherence was measured for oral 
hypoglycemic agents, lipid-lowering agents and angiotensin-converting enzyme. Data was 
obtained from prescription refills for a full year prior to interview. Diabetes self-care was 
measured using the SDSCA. 
Results of the study by Lin et al. (2006) revealed no significant differences in baseline 
characteristics between groups with a mean age of 58.5, female (65%), T2DM (96%), and 50% 
of patients had been treated with an antidepressant in the past 3 months. Pre-randomization, 
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medication nonadherence was high for both intervention and usual care groups, ranging from 20-
30% (Lin et al., 2006). Post-randomization, a slight nonadherence to oral hypoglycemic agents 
was noted in the intervention group compared to usual care over 12 months. Baseline SDSCA 
scores were poor for both groups indicating low adherence to diabetes self-care. At 12 months, 
there was a slight improvement in exercise sessions/week and BMI in the intervention group 
compared to usual care. Otherwise at 12 months follow-up, no significant differences were noted 
between groups. 
Limitations of the study by Lin et al. (2006) include the use of prescription refill data, as 
it does not capture the actual medications taken by patients. Additionally, the sample used in this 
study may not be representative of all patients with diabetes and depression, limiting its 
generalizability. Despite these limitations, the study by Lin et al. highlights that contrary to 
authors' belief; enhanced depression treatment did not have a significant impact of diabetes self-
care. This may be suggestive that patients undergoing specific treatment can only focus on one 
condition at a time, as demonstrated by the decrease in medication adherence to oral 
hypoglycemic agents in the intervention group. This study highlights the need for further 
research to determine the type of intervention suitable for this population. 
Similarly Bogner, Morales, Post and Bruce (2007) conducted a randomized control trial 
that examined a depression treatment program for older adults in the primary care setting. Data 
was obtained from the Prevention of Suicide in Primary Care Elderly: Collaborative Trial 
(PROSPECT) in which participants were recruited from 20 primary care clinics in New York 
City, New York, and Philadelphia and Pittsburgh, Pennsylvania. Participants were randomized 
into the intervention or usual care groups. The intervention consisted of a depression care 
manager who provided the option of a first-line antidepressant and or psychotherapy at no cost. 
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In the usual care group, the participant's physician was notified of the depression and materials 
were provided based on guidelines. The 24-item Hamilton Depression Rating Scale was used to 
measure depressive symptoms. The diagnosis of diabetes was provided by self-report and the 
Philadelphia Multidimensional Assessment Instrument was used to assess activities of daily 
living. Suicidal ideation was assessed using the Scale for Suicidal Ideation and vital statistics 
were obtained 5 years after the completion of PROSPECT. 
The current study by Bogner et al. (2007) analysed data for 584 participants. The mean 
age was 70.3 ± 7.9 years, with an age range of 60-94 years. The sample was comprised of72.3% 
female participants, 69.7% were Caucasian, 27.6% were African American, and 2.7% American 
Indian, Hispanic or Asian. 21.2% of participants identified as having a diagnosis of diabetes. 
Data was analysed according to intervention or usual care groups by diabetes status at baseline. 
Patients with diabetes and depression in the usual care group experienced a mortality rate of 
103.4/1000 person years (95% CI, 63.2-159.7) and patients in the intervention group experienced 
a mortality rate of 68.2/1000 person years (95% CI, 41.0-106.5) (Bogner et al., 2007). After 
adjusting for baseline differences, Bogner et al. found that depressed participants with diabetes in 
the intervention group were less likely to have died at the 5-year follow-up compared to 
depressed participants with diabetes in the usual care group (adjusted HR [95% CI 0.42-1.47]). 
Limitations of the Bogner et al. (2007) study include its location (New York City, 
Philadelphia, and Pittsburgh), as it may not be representative of all primary care practices in 
North America. Additionally this study used self-report of diabetes diagnosis, no information 
was available as to the frequency of appointments and follow-up of patients in the intervention 
group and no information on AlC levels was provided. Lastly, there is potential for 
miscalculation of vital statistics. Despite these limitations, the study highlights that older patients 
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with diabetes and depression who receive depression care management in primary care are less 
likely to die at 5-year follow-up compared to those receiving usual care. 
In summary, analysis of the literature around enhanced depression treatment for patients 
with diabetes revealed that no significant impact was noted on diabetes self-care. However, older 
patients who received enhance depression treatment were less likely to die at five year follow-up. 
These findings suggest that this vulnerable population may require further support from their 
PCP to manage their comorbid conditions. 
Integrated management of diabetes and depression. This section will explore three 
studies that focus on integrated management of diabetes and depression. Bogner, Morales, de 
Vries, and Cappola (2012) performed a randomized controlled study that examined whether a 
simple, brief integrated approach to depression and T2DM treatment improved adherence to oral 
hypoglycemic and antidepressant medications, glycemic control and depression among patients 
recruited from three primary care practices in Philadelphia, Pennsylvania. Inclusion criteria for 
the study were age 30 or older, a diagnosis of T2DM and a prescription for both an oral 
hypoglycemic and antidepressant medication. The study had a 2-week run-in phase that 
consisted of data collection, followed by the randomization of patients into the integrated care 
intervention or usual care. The intervention was administered by two integrated case managers 
and was intended as a supplement and not a replacement of existing care, which consisted of 
three, 30 minute in person sessions (at baseline, six weeks, and 12 weeks) and two, 15 minute 
telephone contacts over a three month period. Additionally, the integrated case manager 
collaborated with the physician to offer education and guideline-recommendations to the 
patients. Medication adherence was measured using the Medication Event Monitoring System 
(MEMS) caps (threshold 80%) which have a microelectronic monitor on the pill bottle and 
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provide the exact date and time of when a container is opened (Bogner et al., 2012). Glycemic 
control was measured using AlC levels and depressive symptoms using the PHQ-9. Electronic 
medical records identified 715 patients of whom 265 were eligible and approached to participate 
in the trial, with 75 refusing to participate. The final sample consisted of 180 patients 
randomized to either integrated care intervention (n=92) or usual care (n=88). 
Bogner et al. (2012) found no significant differences between the intervention and usual 
care group. Demographic characteristics revealed a mean age of 57.4, with just over half African 
American participants, female (68%), AlC 7.1 %, and mean duration of diabetes of 12 years. At 
12 weeks follow-up, 60.9% of patients in integrated care compared to 35.7% of patients in usual 
care achieved an AlC 'S.7%. At 12 weeks follow-up, 58.7% of patients in integrated care 
compared to 30. 7% of patients in usual care achieved remission of depression. In regards to 
medication adherence at 6 and 12 weeks, both oral hypoglycemic (P <.001) and antidepressant 
(P <.001) agents had a significant improvement in integrated care compared to usual care. 
Limitations of the Bogner et al. (2012) study include the use of only three primary care practices 
in Philadelphia, as this may not be representative of all primary care clinics in North America. 
Additionally, the use of MEMS caps (threshold 80%) for assessing medication adherence may be 
limited. Despite these limitations, Bogner et al. have presented a simple intervention that focused 
on adherence to medications that showed higher adherence rates in both oral hypoglycemic and 
antidepressants agents, better glycemic control and decrease in depressive symptoms. 
Similarly, Lamers, Jonkers, Bosma, Knottnerus and van Eijk (2011) conducted a 
pragmatic, randomized controlled trial that examined whether a nurse-administered minimal 
psychological intervention for depressive symptoms improved diabetes specific quality of life 
and glycemic control among older adults (2:60) in primary care practices in the Netherlands. 538 
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participants were approached to participate in the study, with a final sample of 208 who were 
randomized to intervention (n=105) or usual care (n=103) groups. Dropout rate was similar 
among the intervention and usual care groups (33% vs. 30%) and was associated with higher age 
and not with baseline screening scores. The Problem Areas in Diabetes (PAID) scale was used to 
monitor emotional distress and the Diabetes Symptom Checklist - Revised (DSC-R) scale was 
used to assess disease specific quality of life. Al C levels were collected for 65% of participants 
and retrospectively for 46 participants. Data were analysed using SPSS 15 and ANCOVA 
models were used to test the differences between DSC-Rand PAID scores (Lamers et al., 2011). 
Data was presented according to patient allocation of usual care or intervention group. Baseline 
characteristics were shown to be similar among intervention and usual care groups. 
Limited improvement was seen among the intervention group for quality of life at nine 
months follow-up. For participants who had available AlC levels, a decline was noted in the 
intervention group compared to usual care over nine months. Post hoc analysis revealed that 
participants with higher education had a significant improvement in their PAID scores and DSC-
R scores compared to usual care. Additionally, patients in the intervention group with shorter 
diabetes duration (<7 years) had less emotional distress compared to usual care at follow-up (P = 
0.04). A limitation of the study by Lamers et al. (2011) is the small number of AlC levels used 
for analysis, however there was an improvement in A 1 C levels among the intervention group 
that has not been seen in many studies. Additionally, this study highlights the participant's 
education level suggesting that interventions should be individualized based on the patient's 
changing needs and understanding of their chronic conditions. 
A pilot study in the Netherlands by Meeuwissen, Holleman, de Jong, Nuyen and van der 
Feltz-Comelis (2011) explored a diabetes nurse (DN) intervention for screening of depression 
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and anxiety along with self-help for adult patients with T2DM in the primary care setting. The 
DN s worked with 73 GPs in seven general practices or home care services, from which 
participants were recruited. The DNs screened 111 patients for depression and anxiety using a 
written guide. Fifty-five patients screened positive and were interviewed by a researcher using 
the MINI International Neuropsychiatric Interview. Of these, 26 patients screened positive on the 
MINI and 19 patients agreed to take part in the self-help intervention (Meeuwissen et al., 2011). 
The intervention consisted of guided self-help (work book) and one-on-one guidance by the DN. 
Variables measured in this study include depressive symptoms using the PHQ-9, diabetes 
distress with the PAID-NL, and quality oflife was explored using the SF-36 and EuroQol. 
The results of the study by Meeuwissen et al. (2011) revealed seven participants to have 
anxiety, six to have depression and 13 to have both. Mean age was 58.5 (SD 9.86) and 93.3% 
were female. In regards to mental health, 73 .3% of patients found an improvement in one 
measure of the PHQ-9 (depression, anxiety or somatic symptoms). Also, improvement was noted 
in the PAID-NL score, SF-36 and EuroQol at 6-month follow-up. Thus, this was demonstrated to 
be a significant issue. Limitations of this study are its design. Mental health status was analysed 
using the PHQ-9 by being broken down individually by anxiety, depressive or somatic measures, 
making it difficult to follow. Additionally, there was limited demographic data and lack of AlC 
levels. The sample was not diverse, thus limiting its generalizability. Despite these limitations, 
this pilot study highlights the importance of screening for mental health disorders in the diabetic 
population and that guided self-help may improve patient outcomes. 
To summarize, the review of integrated management of diabetes and depression has 
demonstrated that a brief integrated approach to diabetes and depression can improve medication 
adherence, better glycemic control and a decrease in depressive symptoms. Additionally, certain 
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barriers were identified including the patient's education level and its impact on patient benefit 
from intervention. 
Patient centred collaborative care for multimorbidity. Based on the TEAMcare 
model, a number of studies reported on collaborative care interventions for patients with 
diabetes, coronary heart disease (CHD) or both and coexisting depression. For this review four 
studies will be examined and a description of the TEAMcare Study will be provided. 
Katon et al. (2010) conducted a randomized controlled trial that examined collaborative 
care for patients with depression and chronic illnesses (poorly controlled diabetes and or 
coronary heart disease) in the primary care setting in Washington State in the United States. The 
TEAMcare Study recruited participants from 14 primary care clinics in the Group Health 
Cooperative (GHC). Participants were selected from an electronic medical record and those who 
screened positive for diabetes/CHO were mailed the PHQ-2. Those with a score of PHQ-2 2:3 
were followed-up and administered the PHQ-9. Those with a score of PHQ-9 2:10 were eligible 
to participate in the study with a total of 214 participants randomized to intervention (n= 106) or 
usual care (n=108). Of the 214 patients enrolled, 88% completed all the 6-month assessments 
(telephone survey, AlC, and SBP) and 83% completed all the 12-month assessments (telephone 
survey, AlC, SBP, and LDL-C). The 12-month intervention aimed to combine support for self-
care with pharmacotherapy to manage depression, hyperglycemia, hypertension, and 
hyperlipidemia (Katon et al., 2010). Three nurse care managers collaborated with each patient's 
primary care physician to meet the above-mentioned measures by providing treat-to-target and 
medication titration advice. The nurse case managers met with patients at two to three week 
intervals and once the patient achieved target goals for the above-mentioned measures, a 
maintenance plan was developed with the patient. The nurse case managers followed-up with a 
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telephone call every four weeks to assess PHQ-9 and adherence. Disease specific outcomes to 
measure disease control at 12 months include AlC<7% or decrease of 0.5 percentage point; 
SPB<130 mm Hg or decrease of 2:10mm Hg; and LDL-C < lOOmg/DL [<2.6mmol/L] or decrease 
of 2:15% (Katon et al., 2010). Depression status was assessed using the Symptom Checklist-20 
(SCL-20) at baseline, six months and 12 months. Additional outcome measures at six and 12 
months included the Patient Global Improvement Scale and satisfaction with care. In the usual 
care group, patients were advised to seek medical attention in regard to diabetes, CHD and or 
depression. Additionally, with the patient's permission, their physician was notified of the 
above-mentioned conditions and requested laboratory test at baseline, six months and 12 months. 
The results of the study by Katon et al. (2010) revealed that patients in "the intervention 
group had a mean of 10.0 in-person and 10.8 telephone visits with the nurse care manager over 
12 months" (Katon et al., 2010, p. 2616). Baseline characteristic were found to be similar 
between the intervention and usual care group, with a mean age of 56.8 ±11.3 and 49% of 
participants were female . In regards to disease specific outcomes, patients in the intervention 
group compared to usual care had greater overall improvement in AlC, SBP, and LDL-C levels 
(Katon et al., 2010). Furthermore, a 50% decrease in SCL-20 scores was noted in the 
intervention group at 12 months follow-up compared to usual care. Additionally, patients in the 
intervention group were noted to have improved quality of life and were significantly happier 
with the care they received for depression, diabetes, CHD or both. In regards to quality of care, 
the intervention group was more likely to have medication changes (insulin, antihypertensive, 
and antidepressant) compared to usual care. No significant differences were noted in exercise or 
healthy diet of 2:2days/week between groups (Katon et al., 2010). Therefore, the collaborative 
model of care may provide optimized management to this vulnerable and complex population. 
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While the study provided some important insights with respect to supportive 
interventions a number of limitations exist. Limitations include the use of one health plan (GHC) 
and the use of highly experienced nurses in diabetes care, which may potentially limit the 
generalizability. Furthermore, there is potential of spillover of the intervention as the physicians 
ultimately treated patients in both groups. Also, among the usual care group, the number of clinic 
visits is unknown and the difference between groups for hospitalization or cardiovascular events 
is unavailable. Despite these limitations, Katon et al. highlight that collaborative care for patients 
with chronic disease and co-existing depression can have a positive impact on patient outcomes. 
Additionally, there is potential for the TEAMcare model to be utilized for other chronic 
conditions and coexisting depression. This study in part answers my question, as the NP can 
utilize components of the intervention in order to support the diabetic patient with depression. 
Based on the original TEAMcare Study described previously, Lin et al. (2012) examined 
patient and physician behaviours towards medication adherence, self-monitoring and treatment 
adjustment in improving patient outcomes for diabetes, CHD and depression. Study measures 
included medication initiation, adjustment, adherence and disease self-monitoring (Lin et al., 
2012). Medication adherence was calculated using automated pharmacy refill data for 12 months 
before and after baseline. Medication adjustments included initiation, later medication changes, 
and assessed incidence with intervals between baseline, 30 days, 60 days, 90 days and 12 
months. Additionally, five classes of medications were examined (antihypertensive agents, oral 
hypoglycemic agents, insulin, lipid-lowering agents, and antidepressant agents). The SDSCA 
scale was adapted and used to assess the frequency of SMBG and BP measurements. 
The results of this study examined pharmacy data for 181 patients, 91 intervention 
participants and 90 usual care participants (Lin et al., 2012). As mentioned previously by Katon 
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et al. (2010), no significant baseline characteristic differences existed between the intervention 
and usual care groups, with the exception of the intervention group receiving more oral 
hypoglycemic agents compared to usual care (Lin et al., 2012). Outpatient visits during the 12 
months for both groups were similar (intervention= 11.4, usual care= 12.3) and telephone visits 
(intervention= 10.1, usual care= 10.3) (Lin et al., 2012). Medication adherence was found to be 
high at baseline among both groups for oral hypoglycemic agents (83%), antihypertensive agents 
(85%), lipid-lowering agents (83%), and antidepressant agents (79%) with no significant change 
during the 12 month study. At 12 months, the intervention group performed more frequent home 
BP and SMBG compared to usual care. Initiation rates of antidepressant agents, lipid-lowering 
agents, antihypertensive agents and insulin were higher among the intervention group compared 
to usual care over the 12 months. Similarly, significant differences were noted in medication 
adjustments for all five classes of medication in the intervention group compared to usual care 
(Lin et al., 2012). For the most part, the first adjustment of medication occurred within two 
months of the intervention start. Significantly higher rates of first medication adjustment were 
noted for three classes of medication: antidepressant agents, antihypertensive agents and insulin 
(Lin et al., 2012). Therefore, the collaborative care model may provide optimized 
pharmacological support for this complex population. 
Limitations of the study by Lin et al. (2012) are similar to previously mentioned 
limitations in the original study by Katon et al. (2010). Additionally, prescription refill data was 
used to measure medication adherence and the focus on chronic conditions may limit the 
generalizability (Lin et al., 2012). Despite theses limitations, Lin et al. provide the results for 
outpatient visits that were previously unavailable in the Katon et al. (2010) study, demonstrating 
that both groups had similar outpatient and telephone visits. Additionally, medication initiation 
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and or adjustment occurred more frequently and earlier in the intervention group, suggesting that 
the support from nurse care mangers aided the physician in making prompt medication changes. 
Interestingly, in a follow-up study Lin et al. (2014) followed the same participants at 6, 12, 18, 
and 24-month intervals to determine the clinical benefit of collaborative care. Lin et al. (2014) 
found that the benefit of intervention continued at 24 months for CHD risk factors with a slight 
deterioration in AlC. Additionally, benefit of the intervention was seen as early as 6-months 
follow-up, specifically in patients with uncontrolled diabetes and or CHD risk factors (Lin et al., 
2014). 
The last study in this section is a controlled implementation trial by Johnson et al. (2014), 
which examined collaborative care for patients with diabetes and depressive symptoms in non-
metropolitan Primary Care Networks (PCN) in Alberta, Canada. The study design was largely 
based on the TEAMcare study mentioned at the beginning of this section (Katon et al., 2010). 
Participants were recruited from 14 PCNs in rural Alberta from November 2010 to January 2013. 
To be considered for the study, participants had to have a diagnosis of diabetes, and be an adult 
(2:18) with a PHQ-9 2:10 (Johnson et al., 2014). Patients were randomized using a controlled "on-
off' time series method into intervention or active control (Johnson et al. 2014). However, one 
variable was added to this study, which was the use of a non-screened usual care group and the 
participants were part of the Alberta Caring for Diabetes (ABCD) Cohort Study. The non-
screened usual care group had depressive symptoms assessed using the PHQ-8 and no 
information was available for this group for AlC level, SBP, or LDL-C (Johnson et al., 2014). 
Screening packages were mailed to 7,846 patients with a response rate of 35% of whom 71 % 
were initially eligible. Of these, 25% of patients had a PHQ2:10. 175 patients were enrolled into 
intervention (n = 95) or active control (n = 62), and 71 patients were assigned to the non-
screened usual care group (Johnson et al., 2014). 
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Results of the study by Johnson et al. (2014) revealed similar baseline characteristics 
between intervention and active control groups, with a mean age of 57.8 (SD 9.8), female (55%), 
BMI >30kg/m2 (75%), mean PHQ-9 of 14.5 (SD 3.7), AlC of 7.6% (SD 1.8%), SBP of 
125.2mm Hg (SD 15.9), and LDL-C of2.2 mmoVL (SD 0.8). The non-screened usual care group 
had similar baseline characteristics, with a mean PHQ-9 of 14.2 (SD 3.4) and 54% were female, 
although patients were slightly older with a mean age of 63.4 (SD 11.3). At 12-month follow-up, 
the intervention group had greater improvement in PHQ-9 of 7.3 (SD 5.6) compared to the active 
control group with a PHQ-9 improvement of 5.2 (SD 5.7). Recovery of depressive symptoms 
was seen in 61 % of intervention patients compared to 44 % of active control patients. The non-
screened usual care group had less of an improvement in the PHQ-9 of 3.2 (SD 4.9), only 24% 
had recovery, and 39% of patients had improvement in depressive symptoms over 12 months 
(Johnson et al., 2014). No significant differences were noted for condition specific outcomes 
including AlC, SPB or LDL-C in both groups (Johnson et al., 2014). Given this study was 
conducted in Canada, it can provide important and relevant contextual insight on the 
management of diabetes and depression. 
While this study provides insight to the management of diabetes and depression, a 
number of limitations exist. Limitations include the use of controlled allocation of patients versus 
randomization and the case manger was not blinded to allocation. Additionally, 43 patients did 
not complete the study. However, no significant differences were noted between groups thus 
reducing the risk of bias. Despite these limitations, the study by Johnson et al. (2014) adds 
valuable information regarding depression treatment in the Canadian primary care setting. 
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Noteworthy are the significant differences in PHQ-9 scores between the three groups at 12-
month follow-up, specifically the non-screened usual care group. This highlights the need to 
screen patients with chronic conditions for depressive symptoms. Additionally, the patients in 
this trial had relatively good control of disease specific measures (Al C, SBP, LDL-C) at baseline 
compared to the study by Katon et al. (2010) in which patients had poorly controlled diabetes 
and or CHD. 
In summary, review of the literature on patient centred collaborative care for 
multimorbidity revealed significant benefit from intervention for disease specific measures 
including AlC levels, SBP, and LDL-C levels. Furthermore, the review of the literature noted a 
decrease in depressive symptoms, improved quality of life and greater satisfaction with care 
received by this complex population. The authors within this section partially answered my 
research question offering suggestions for the care required for this vulnerable population. 
Patient Perception of Care 
The lived patient experience of having diabetes and depression and the care desired by 
these patients was a key subtheme that emerged from the analysis of the literature. Four studies 
were identified that focused on the impact of living with diabetes and depression and the desired 
care by these patients. Key findings included the patients' understanding of having comorbid 
conditions and the challenges associated with living with diabetes and depression. Additionally, 
patients desired support from their PCP in managing their conditions. 
McSharry, Bishop, Moss-Morris and Kendrik (2013) conducted a qualitative study that 
examined multimorbidity with a focus on the content of cognitive representations and reported 
management of diabetes and depression. Participants were recruited from eight general practices 
in Southampton City and Hampshire Primary Care Trusts, England. Each practice mailed out a 
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package to 10 patients and of the 80 patients approached, 38 agreed to participate. After 
maximum variation sampling, the final sample consisted of 17 patients. Of these, eight patients 
were female, nine were male, and aged 31-78 years of age. 15 patients had T2DM, eight had 
diabetes pre-depression, seven had depression pre-diabetes and two were diagnosed with 
depression and diabetes the same year. The author conducted semi-structured face-to-face 
interviews either in the patient's home or at the general practice clinic. The interview was guided 
by open-ended questions exploring the nature of cognitive representations and self-management 
related to both diabetes and depression. The interviews were audiotaped, transcribed verbatim 
and entered into QSR NVivo 8. This was followed by an inductive thematic analysis guided by 
grounded theory for the study of chronic disease (McSharry et al., 2013). 
The results of the study by McSharry et al. (2013) found that patients with diabetes and 
depression perceived the relationship differently between the two conditions. The first theme 
identified six patients as believing that diabetes and depression are unrelated, and the following 
quote captures this cognition "[d]iabetes is obviously being managed by medication and 
obviously what I eat ... obviously I take medication for depression as well, that was due to 
family problems" (McSharry et al., 2013, p. 109). Additionally, McSharry et al. identified 
secondary themes evident in this group, including dominant other condition and alternative 
depression cause which was demonstrated by the above quote. Conversely, 11 participants 
identified with the second theme of diabetes and depression as being related and the following 
quote exemplifies this notion: 
It interacts with each other, if that makes sense, depending on how I feel that day, 
depending on whether I want to do exercise. If I do exercise I'll feel better and my sugar 
level will be lower. It is difficult. If! wake up and feel really miserable and not wanting 
to do anything, then I know that day my sugar' s going to be all over the place. So I don't 
know what makes, what way around, the chicken and egg thing - whether I feel 
depressed because my sugar level is all over place. (p. 111) 
The third theme identified was the representation of confidence. Participants had higher 
confidence when experiencing perceived control over their self-care activities and sought out 
their PCP to confirm their progress whereas those with less confidence looked to their PCP or 
family for added support and information in regards to their conditions. 
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Lastly, multi-medication use became evident across the whole sample, with some patients 
having limited understanding of their medications. Interestingly, some patients found that 
diabetic agents helped to control their diabetes, without worry about side effects. Conversely, 
antidepressant agents were seen as controlling and caused worry for patients about side effects 
and long-term use. This information adds valuable awareness of the patient perspective in 
regards to certain medications and for that matter medication adherence for this population. 
While these findings add insight into the patient perspective, some limitations exist. Limitations 
of the study include its small sample size and lack of ethnic diversity, limiting its 
generalizability. However, McSharry et al. highlight the patient perspective of diabetes and 
depression and whether the two conditions are related. This is valuable information for the 
primary care provider, as being aware of the patient's perception can guide the care provided. 
Whiting, Scammell, Gray, Schepers and Bifulco (2006) conducted a mixed quantitative 
and qualitative study that examined the experiences of people living with T2DM and depression, 
and the role of primary care in meeting the patient's needs. Additionally, this study examined the 
relationship between diabetes, depression and self-care. Participants were recruited from seven 
practices in Wandsworth Primary Care Trust, England. Questionnaires (SDSCA, Hospital 
Anxiety and Depression [HAD], List of Threatening Experience [LTE]) were used to assess 
diabetes self-care, depression and stress. Those who scored high on the HAD (::::8) scale were 
asked to participate in an interview and of these, a final sample of 16 participants agreed. Semi-
structured face-to-face interviews were performed either in the patient's home or in the 
researcher's office by one of the authors. The interviews were audiotaped, transcribed 
anonymously and analysed thematically using the framework approach with ATLAS.ti 5.0. 
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Three hundred and eighty nine questionnaires were returned with a response rate of 
33.8%. The results of the questionnaire revealed 54% of participants to be male, White British 
(31. l %), Black or Black British (35.7%), Asian or Asian British (24%), and Chinese or other 
(9%). Whiting et al. (2006) found 31% of participants to have depressive symptoms (19.3% mild 
depression, 12.6% moderate to severe depression). As with other studies, depressed participants 
reported having lower adherence to exercise and healthy diet compared to non-depressed 
patients, and no significant difference was found between groups for SMBG. Medication 
adherence was not assessed, as a large portion of the sample was not taking an oral 
hypoglycemic agent or insulin. In regards to stress, an association was found between stress and 
depressive symptoms, and stress and lower self-care. 64.6% of participants reported having 
experienced one threatening event in the past 6 months. Additionally, these participants scored 
higher on the HAD scale, were more likely to report depressive symptoms and had lower 
adherence for exercise and healthy diet (Whiting et al., 2006). 
The analysis of the interview data from the Whiting et al. (2006) study revealed three 
themes. The first theme explored the effect of depression and stress on diabetes. Participants 
reported having a negative outlook on their diabetes and difficulty adhering to diabetes self-care 
while experiencing a depressive episode. The second theme explored the effect of diabetes on 
depression, participants found poor diabetes self-care impacted their stress and depression. 
Additionally, the diagnosis of diabetes was found to be a stressful life event and some 
participants thought it might have been the trigger for their depression (Whiting et al., 2006). 
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Anxiety was found to be a response to long-term complications and limitations due to diabetes 
self-care. Lastly, the third theme examined support from primary care for patients with diabetes 
and depression (Whiting et al., 2006). Participants reported not having adequate support for their 
emotional day-to-day needs of living with diabetes. Additionally, some participants reported not 
letting their primary care provider know about their depression as they found it to be a cultural 
taboo (Whiting et al., 2006). 
The main aim of this study was to identify participants suitable for interview and the 
study had a diverse ethnic sample. Additionally, this is one of the first studies to encompass a 
mixed method approach to explore diabetes and depression. Whiting et al. (2006) highlight the 
challenges faced by patients with diabetes and depression, and the need for primary care 
providers to take this into consideration. However, a limitation of the study was identified and 
includes the questionnaire phase of the study with a low response rate of 33.8%. 
Similarly, Bayliss, Edwards, Steiner and Main (2008) conducted a qualitative study that 
explored the processes of care desired by elderly (~65) patients who have multimorbidities in 
order to inform development of future interventions to improve patient care. This study was part 
of a larger project that assessed barriers to self-management for persons with multimorbidities. 
At minimum participants had to have diabetes, depression and osteoarthritis. These three 
conditions were chosen specifically, as they can pose challenges in treatment compared to 
similar treatment options offered for hypertension and coronary heart disease. Three hundred and 
fifty seven eligible participants were approached from a single Health Maintenance Organization 
(HMO) with a final sample of 26 participants. The characteristics of the study sample included 
50% of males, 12 participants aged 65-74, 14 participants aged 74-84, 10 participants had four to 
nine chronic conditions and 16 participants had 10-16 chronic conditions. Semi-structured 
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interviews were conducted to extract the process of care desired by elderly patients. The 
interviews were audiotaped, transcribed and analysed thematically using Atlas Ti software. 
Additionally, two of the authors independently reviewed the data for themes and the third author 
acted as an external auditor (Bayliss et al., 2008). 
Analysis of the qualitative data revealed four themes. These are convenient access to 
providers (telephone, internet or in person), continuity of care, clear communication of care plan, 
and individualized and coordinated care (Bayliss et al., 2008). Additionally, patients wanted to 
be "heard and understood" (Bayliss et al., 2008, p. 291 ). Specifically, the theme of individualized 
and coordinated care had a strong presence and one participant with 15 conditions describes the 
need as: 
I still think [it would be helpful] if in the primary care department ... you would be seen 
by someone kind of on a regular basis every 3 months, every 4 months ... so you could 
kind of bring everything together ... all the different things that you are caring for ... [my 
doctor] wouldn't have to do it herself, because she is so busy . .. but where her nurse 
practitioner could kind of go over and study what is going on with me with the different 
things and if she needs to talk to one of my specialists . . . Just someone who kind of has 
everything studied so you can come in and talk about it. (p. 291) 
This is a clear demonstration of the continuity of care that these patients desire. The amount of 
quotes was reasonable in relation to the identified categories. Limitations of this study are the use 
of one HMO group and the nature of the sample as the extent of multimorbidity limits 
generalizability. The authors found that elderly patients desired patient centred care with a single 
coordinator of care or a contact person who would be able to understand and support the 
changing needs of each patient. 
The last study in this section is a qualitative study by Gask, Ludman and Schaefer (2006) 
that examined the communication between depression care specialist (DCS) nurses and 
depressed patients with diabetes. This study was part of the Pathways Study described earlier by 
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Lin et al. (2006) . Patients were offered a choice of evidence-based treatment: an antidepressant 
or problem solving treatment for primary care (PST-PC). The PST-PC includes seven stages of 
problem solving 1) defining and breaking down the problem, 2) establishing a realistic goal, 3) 
brainstorming multiple solution alternatives, 4) implementing decision-making guidelines, 5) 
evaluating and choosing the solution, 6) identifying specific steps for plan of action, and 7) 
evaluating the outcome after solution has been implemented (Gask et al., 2006). The DCS nurses 
were meant to provide depression care and followed a step-care algorithm depending on patient 
response to treatment. Diabetes related care was not part of the intervention, unless it came up in 
the consultation. The author reviewed a total of 30 audiotaped consultations between 3 DCS 
nurses and 25 patients. The consultations were transcribed and thematically organized. Three 
themes emerged including complex patient problems, difficulties in therapy, and managing 
change. 
Gask et al. (2006) found that in regards to complex patient problems, aside from having 
diabetes and coexisting depression, patients were found to have other health related problems 
and struggled to manage their diabetes. Additionally, some patients found family members to be 
of support whereas some found them to be a hindrance. In regards to difficulties in therapy, the 
DCS nurses were able to utilize structured problem-solving techniques and counselling to guide 
the consultation. Conversely, at times the DCS nurse gave advice as opposed to using problem-
solving techniques. Additionally, it was found that with a less experienced DCS nurse, the nurse 
tried to identify with the patients and give their own interpretation of the situation. In regards to 
managing change, when patients were posed with the idea of change the DCS nurses utilized 
motivational interviewing and counselling strategies to guide the conversation. This was an 
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effective strategy, as some patients did not understand the treatment, want to engage and/or were 
unable to acquire new skills (Gasket al., 2006). 
Limitations of the study by Gask et al. (2006) include the use of audiotapes post study 
completion, as patient characteristics were unavailable and not all consultations were reviewed 
and analysed, as they were not recorded. Additionally, patient perspective on the intervention 
was not captured as no follow-up interviews were conducted. Despite these limitations, the study 
by Gask et al. (2006) highlights the challenges posed by this population in primary care, 
specifically for novice primary care providers. To overcome this challenge, the authors suggest 
the use of the problem solving treatment for primary care along with motivational interviewing, 
which requires switching back and forth between medical and psychological domains. 
In summary, review of the literature based on the patient perspective of living with 
diabetes and depression revealed valuable information for practice. The patient's cognition of 
comorbidity, perceiving the diagnosis of diabetes as a life threatening event and understanding of 
medications became apparent and knowledge of this patient perspective can guide the PCP in 
practice. Additionally, review of the literature revealed the care desired by this population 
including easy access to care, continuity of care, clear communication and individualized 
coordinated care. Again, this is invaluable information that can guide the PCP in providing care 
to this vulnerable population. 
Overall, analysis of the literature has demonstrated the association of diabetes and 
depression and specifically the negative impact on diabetes self-care. For this integrative 
literature review a final cohort of 18 studies was critically appraised. Three themes were 
identified and these are 1) the effect of depression on diabetes self-care, 2) interventions for 
patients with diabetes and depression, and 3) patient perception of care. Key messages include 
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the need to identify and screen diabetic patients for depression, provide on-going support in the 
management of both conditions and ensure a patient centred approach to treatment. Furthermore, 
the current findings add substantially to our understanding of a patient's lived experience with 
diabetes and depression that can inform future practice. However, these findings are limited by 
the use of cross-sectional design, the use of self-reported and prescription refill data, and the 
locations for each study as they may not be representative of all primary care practices in North 
America. Despite these limitations, taken together, these findings suggest a role for the NP in 
promoting self-care for the diabetic patient with depression. The following chapter will provide 
the discussion of this integrative literature review. 
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CHAPTER4 
Discussion 
This integrative review of the existing literature has demonstrated the relationship 
between diabetes and depression, and specifically the negative impact that depression has on 
diabetes self-care activities (Bell et al., 2010; Dirmaier et al., 201 O; Egede et al., 2009; Lin et al. , 
2004). A review of 18 studies was undertaken. This discussion section will provide an overview 
of the key findings along with recommendations for practice, research and education. 
The Effect of Depression on Diabetes 
Demographic characteristics. The findings suggest that certain demographic 
characteristics are associated with depressive symptoms among diabetic patients. Based on the 
literature reviewed, higher rates of depression were associated with being female (Bell et al., 
2010; Dirmaier et al., 2010; Egede et al., 2009; Lin et al., 2004), having a lower income and or 
education level (Bell et al., 2010; Egede et al., 2009) and having a perceived health status as 
fair/poor (Bell et al., 2010; Egede et al., 2009). Additionally, Lamers et al. (2011) findings 
suggest that a patient's educational level may play a pivotal role as to the interventions provided 
for each patient. Similar findings have been found among the growing number of chronic 
conditions such as HF and chronic obstructive pulmonary disease (COPD) (Rutledge et al., 2006; 
Schneider, Jick, Bothner, & Meier, 2010) demonstrating the global nature of chronic conditions 
and depression in the primary care setting. 
These findings highlight the importance of being vigilant in screening patients with 
certain demographic characteristics for depressive symptoms. Patients from a lower 
socioeconomic status are already at risk of poorer health outcomes and the addition of diabetes 
may further escalate these poor health outcomes. For example, in Canada, the Aboriginal people 
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are known to be at risk of developing T2DM and associated complications at a younger age 
(PHAC, 2011). Additionally, the prevalence of T2DM is higher among Aboriginal women and 
higher rates of GDM have also been reported (PHAC, 2011). Findings from this review 
identified only one study by Bell et al. (2010) that had an adequate ethnic representation of rural 
American Indians in North Carolina. Further research is warranted inclusive of the Canadian 
Aboriginal people. When constructing a care plan for all patients, being cognizant of the 
patient's education level and or financial status may be of benefit. What is clear from these 
findings is the need for emotional and psychological support that is individualized and specific to 
a patient's needs . NPs can accomplish this by actively listening to their patients and by being 
empathetic. Furthermore, the NP or other PCP, can assess the patient's need for further 
education, self-management skill level, self-efficacy, and emotional status (Pearce et al. , 2013). 
Diabetes self-care. Depression was associated with poor diabetes self-care activities. 
Significant differences were found for patient adherence to healthy eating, lack of exercise, 
higher rates of smoking, poor glycemic control, and medication nonadherence compared to non-
depressed patients (Bell et al., 2010; Dirmaier et al., 2010; Egede et al. , 2009; Lin et al., 2004). 
With regards to medication nonadherence, not taking oral hypoglycemic agents as prescribed can 
present a problem as glycemic control is compromised. Additionally, lack of exercise and a 
healthy eating plan may further contribute to poor glycemic control and increase the risk of 
complications. These findings suggest that when a patient has poor control of their diabetes, 
screening for depression is warranted. It is therefore critical that primary care providers, and 
other members of the interdisciplinary team are well informed about the impact of these two 
conditions and the compounding effects of diabetes and depression on self-care practices. T2DM 
is on the rise worldwide, with no signs of slowing down (WHO, 2015). Given that poor control 
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of diabetes results in costly complications and that diabetic patients with depression utilize more 
health care dollars (Dufton et al., 2007), this is a real threat to the Canadian health care system. 
Therefore, examination of patient outcomes can provide valuable information regarding the 
delivery and effectiveness of the interventions being provided to this vulnerable population. 
Quality of care. An analysis of the literature indicated that healthcare providers are less 
likely to follow the recommended clinical guidelines for patients with diabetes and depression 
compared to those with no depression (Egede et al., 2009; Egede et al., 2010; Lin et al., 2004). 
One could argue that this may be due to the patient not showing up for their scheduled 
appointment or it might be that these patients are complex and pose a challenge for their health 
care providers. Regardless of the reason, diabetes preventative care is part of providing excellent 
quality care. Given that the majority of patients with diabetes receive care by a PCP, it is 
essential that these patients be not only screened for depression but also with disease specific 
measures such as retinal eye exams or foot exams. Additionally, Egede et al. (2010) found that 
depressed females were less likely to receive guideline care for breast screening compared to 
non-depressed females with diabetes. These findings suggest that this population is not only 
vulnerable to less disease specific care but are also subject to suboptimal preventative care. This 
is worrisome, as the cost of diabetes is escalating at an alarming rate and with poor preventative 
measures these costs are bound to increase. NPs are uniquely positioned to meet the needs of this 
population as they can provide comprehensive care that is patient-centred and holistic in nature 
(CNA, 2010; Kuo et al., 2015; La Vance et al., 2015; Pearce et al., 2013; Richardson et al., 2014). 
Interventions for Patients with Diabetes and Depression 
A synthesis of the reviewed studies further highlights three main interventions for 
patients with diabetes and depression. These are 1) enhanced depression treatment, 2) integrated 
management of diabetes and depression, and 3) patient centred collaborative care for 
multimorbidity. 
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Enhanced depression treatment. The findings in this section suggest that enhanced 
depression treatment for diabetic patients with depression had minimal effect on diabetes self-
care activities (Lin et al., 2006). However, Bogner et al. (2007) found that patients aged 60 years 
and older, with diabetes and depression that received enhanced depression treatment were less 
likely to have died at five-year follow-up. It is possible that older patients have had diabetes for a 
longer period of time; thus have a better understanding of their diabetes management. 
Regardless, this suggests that older patients with diabetes and depression benefit from enhanced 
depression treatment. Additionally, these findings suggest the need for further research to 
explore the optimal interventions for patients with diabetes and depression. 
Integrated management of diabetes and depression. The review of the literature 
suggests that patients with diabetes and depression can benefit from integrated management of 
diabetes and depression (Bogner et al., 2012; Lamers et al., 2011). The findings showed that a 
simple intervention can result in higher medication adherence, better glycemic control and less 
depressive symptoms (Bogner et al., 2012; Lamers et al., 2011, Meeuwissen et al., 2011). 
However, Lamers et al. identified a subgroup of diabetic patients who benefited less from 
intervention, including those with a lower education level, being a woman, and having diabetes 
for a longer duration (?.7 years). As mentioned earlier, certain demographic characteristics place 
a diabetic patient at higher risk of developing depression. These additional findings demonstrate 
that not only are these patients at higher risk of developing depression but are also at a 
disadvantage when it comes to benefiting from interventions aimed to improve both diabetes and 
depressive symptoms. These findings suggest that certain subgroups of patients with diabetes 
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may need additional consideration when constructing a plan of care and further research is 
warranted for this population. Similar findings were identified by Bos-Touwen et al. (2015) in 
their cross-sectional survey of patients with diabetes, COPD, HF, and chronic renal disease. 
Therefore, it is imperative that PCPs be aware of this vulnerable subgroup of patients and tailor 
interventions as necessary to achieve improved patient outcomes. 
Patient centred collaborative care for multimorbidity. The analysis of the captured 
literature demonstrates a shift in working with patients with diabetes and depression. The recent 
development of collaborative care for patients with multimorbidities, specifically those with 
depression, diabetes and or CHD shows significant promise in the care of these complex patients. 
The TEAMcare collaborative care model as described by Katon et al. (2010) has shown an 
improvement in disease specific patient outcomes including AlC, SBP, and LDL-C levels, and 
found that benefit of intervention was seen as early as 6 months for patients with poor baseline 
control (Lin et al. , 2014). These findings suggest that a collaborative approach to caring for 
patients with multimorbidities has significant impact on patient health outcomes. Further 
research is needed to explore the mechanisms and outcomes of team-based approaches to the 
care of patients with depression and diabetes. Understanding this further could have widespread 
impact for this vulnerable population, along with others with multiple or complex chronic 
conditions. 
Given these findings, patients with diabetes require initial screening for depressive 
symptoms in order to improve patient health outcomes. However, screening practices for 
depression among patients with diabetes in the primary care setting were found to be suboptimal 
in this review (Johnson et al., 2014). These findings suggest that screening for depression may be 
being missed in practice. Given that depression is associated with poor self-care activities among 
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patients with diabetes, this is cause for concern. Surprisingly, screening recommendations for 
depression are in conflict in the primary care setting. The Canadian Task Force on Preventive 
Health Care ([CTFPHC], 2013) does not recommend routinely screening for depression whereas 
the United States Preventative Services Task Force ([USPSTF], 2016) does recommend routinely 
screening for depression. These differing recommendations may pose a dilemma for the PCP and 
may impact upon a consistent approach to screening and management. Therefore, greater clarity 
is warranted to assist PCPs when applying clinical practice guidelines, particularly for patients 
with multiple chronic conditions where there may be multiple relevant guidelines. 
Another contributing factor to poor patient health outcomes is medication nonadherence. 
Interestingly, the TEAMcare study found baseline medication adherence to be high between both 
groups. However, more frequent changes and initiation of medications to control depression, 
CHD and diabetes occurred in the control group (Lin et al., 2012). The analysis of the findings 
indicated that patients with diabetes and depression may not be prescribed optimal doses of 
medication, specifically antidepressants, antihypertensives, and insulin (Johnson et al., 2014; Lin 
et al. , 2012). As such, the treat-to-target approach utilized in the TEAMcare model may be of 
benefit to improve patient outcomes. Additionally, PCPs may require supplementary support for 
managing these complex patients. 
Despite the improved patient outcomes, the analysis of the literature shows that a gap still 
exists in patient adherence to healthy eating and physical activity (Bell et al., 201 O; Egede et al., 
2009; Lin et al., 2004; Whiting et al., 2006). Regardless of disease status, these activities are part 
of a healthy lifestyle and need be encouraged for all patients to prevent further complications, 
specifically those with chronic conditions such as diabetes, depression, CHD and HF (Ades et 
al. , 2013; Cole, Smith, Hart, & Cupples, 2011; Katon et al., 2010). Further research is necessary 
to understand the link between patient nonadherence to healthy eating and physical activity 
among this population. Given the rise of chronic disease, future research and practice 
innovations are warranted to optimize the management and outcomes for chronic disease. 
Patient Perception of Care 
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The review of the literature revealed insight into the patient's understanding of living 
with comorbid diabetes and depression, and the care these patients wish to receive. This 
invaluable information can guide the PCP in constructing an individualized plan of care in order 
to support the patient with diabetes and depression. Additionally, a patient's understanding of 
their condition is essential in providing optimal care. Given that some patients believe that 
diabetes and depression are related; this may alter the plan of care compared to patients who hold 
the opposite view (McSharry et al. , 2013; Whiting et al. , 2006). For example, Whiting et al., 
(2006) in their mixed method study explored the experiences of people living with T2DM and 
depression, and found that poor diabetes self-care impacted the patient's stress and depression 
level. These findings demonstrate the ongoing battle a patient with diabetes and depression faces 
when living with the compounding conditions. These findings are similar to other literature that 
has addressed the impact of other chronic conditions such as AMI and HF (Lossnitzer et al., 
2013; Rutledge et al. , 2006) demonstrating that living with multiple co-morbid conditions can 
have a major impact upon the person and those around them. 
A noteworthy finding from this review is that the diagnosis of diabetes was perceived as 
a life threatening experience and some patients attributed this to be the trigger for their 
depression (McSharry et al. , 2013 ; Whiting et al. , 2006). Additionally, some held the belief that 
antidepressant agents were seen as controlling while diabetic medications were seen as helpful in 
managing their diabetes (McSharry et al., 2013). Patients reported that polypharmacy was a 
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significant burden and that they experienced difficulties in adhering to diabetes self-care while 
having depression (McSharry et al., 2013 ; Whiting et al. , 2006). This could suggest that a 
patient's understanding of their treatment plan may be misconstrued and as a result contribute to 
medication nonadherence and ultimately poor patient health outcomes. As such it is important 
that PCPs be cognizant of the patient' s understanding and care desired by this population. 
From the analysis of the literature, it became evident that there is a lack of support from 
the PCP in caring for this population (Bayliss et al. , 2008; Whiting et al. , 2006). Patients desire 
convenient access to PCPs, continuity of care, clear communication, along with individualized 
and coordinated care (Bayliss et al., 2008). Ideally, these findings can guide the PCP when 
implementing a plan of care for this population. 
The Role of Nurse Practitioner in Working with the Patient with Diabetes and Depression 
NPs frequently provide care for complex patients and those with diabetes and depression 
are no exception. Additionally, managing patients with multiple co-morbid conditions can pose a 
challenge, as multiple guidelines may be applicable. The NP has been shown to be an effective 
PCP for those with diabetes (Kuo et al. , 2015). In particular, the NP is well positioned to assess 
patient risk, provide targeted education, prescribe medications, order laboratory investigations, 
collaborate, support and counsel patients with diabetes and depression, and to collaborate with 
other members of the health care team including specialist providers (CRNBC, 2015a). 
Furthermore, the NP may embrace new methods of supporting these patients though virtual care, 
including telephone and Internet based visits. Given the geographical layout of BC, this may be 
of benefit in improving access to care, particularly for those who are located in rural or remote 
settings that may otherwise lack ready access to care. Patients with diabetes and depression are 
costly to our healthcare system and as such, require the necessary investment and support in 
order to assist them to undertake self-care behaviours and lead healthy lives. Based on the 
analysis and synthesis of this integrative review, recommendations for practice, research and 
education were identified. These will now be presented and summarized in Appendix D. 
Recommendations for Clinical Practice 
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The review of the relevant literature demonstrated the utility of screening diabetic 
patients for depressive symptoms (Bell et al., 2010; Dirmaier et al. , 2010; Egede et al. , 2009; Lin 
et al., 2004). Early recognition of depressive symptoms offers an opportunity to provide support 
and education to this vulnerable population. Therefore, it is recommended to screen for 
depressive symptoms at the diagnosis of diabetes, in patients with poorly controlled diabetes and 
at each follow-up visit. Given the busy nature and time constraints of primary care clinics, the 
PHQ-2 can be utilized to screen for depression (Arroll et al. , 2010; Kroenke et al., 2001). An 
answer of yes to either question warrants further investigation. Furthermore, certain populations 
may be at increased risk of depression (female, low socioeconomic status, and longer duration of 
diabetes) and warrant screening (Bell et al., 2010; Dirmaier et al. , 2010; Egede et al. , 2009; Lin 
et al. , 2004). Therefore, healthcare providers should be attuned to those most at risk of 
complications and poor outcomes. 
Once a diagnosis of depression is made, treatment options need to be discussed in 
partnership with the patient. Given the fundamental therapeutic nature of nursing, the NP can 
promote a non-judgemental and supportive role for this population. Furthermore, the review of 
the literature demonstrated that antidepressant dosing may not be optimal in the primary care 
setting (Johnson et al., 2014; Lin et al., 2012). Therefore, it is recommended that NPs stay 
current on evidence-based treatments for depression and prescribe/titrate antidepressants 
appropriately. Additionally, NPs can support the patient by providing non-pharmacological 
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therapies such as CBT. For patients unresponsive to pharmacological and non-pharmacological 
therapies, referral is warranted. 
The review of the literature demonstrates the use of the TEAMcare collaborative model 
in clinical practice and its positive impact on diabetes self-care activities (Johnson et al. , 2014; 
Katon et al., 2010; Lin et al., 2014). However, the PCPs utilized in these studies are GPs. Given 
that NPs are PCPs who care for patients with diabetes and depression the NP could also be 
integrated into the TEAMcare model. Additionally, for NPs who already work in collaborative 
primary care practices with other NPs, GPs and RNs, the TEAMcare collaborative model can be 
easily implemented for the management of the depressed diabetic patient (Johnson et al., 2014; 
Katon et al., 2010). 
Surprisingly, review of the literature demonstrates that diabetes clinical guidelines are 
less likely to be followed by health care providers for patients with diabetes and depression 
(Egede et al. , 2009; Egede et al., 201 O; Lin et al., 2004). Given the rising cost of diabetes and 
depression related complications on our healthcare system (Dufton, et al., 2007), NPs should be 
well versed in diabetes clinical guidelines to provide optimal care to these patients. Hence, the 
need to focus on monitoring the implementation of clinical guidelines and the outcomes of 
patient care, including the collection of population and practice-specific data to track outcomes. 
Greater awareness of guideline-based clinical practice, particularly for those with complex and 
multiple conditions, is much needed. 
Recommendations for Research 
The review of the literature identified a gap that exists in the uptake of screening patients 
for depression in primary care (Johnson et al. , 2014). Given that there are differing views to 
screen for depression in primary care, it is recommended that further research be undertaken at 
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the primary care level to determine the uptake and screening practices of depression by PCPs. 
This in turn can guide evidence-based practice and ultimately lead to a change in guideline 
recommendations. Furthermore, review of the literature shows great promise in utilizing the 
TEAMcare collaborative model to improve patient outcomes for patients with diabetes and 
depression. As such, further research utilizing this model with the integration of NPs is 
warranted, in particular to identify how this impacts upon patient outcomes. Further, a future 
study investigating the use of this model in the context of multiple chronic conditions would be 
very exciting and would provide much needed data for those delivering clinical care. Other 
research may also explore the role of new technologies such as e-visits and other mechanisms of 
virtual care. Lastly, in BC, NPs have been in practice for over a decade and it would be exciting 
to examine the delivery of healthcare by NPs for patients with multiple chronic conditions. 
Recommendations for Education 
The review of the relevant literature demonstrates a need for further education, both for 
patients and PCPs. In order for PCPs to provide optimal patient care, effective strategies are 
required to ensure that PCPs deliver evidence-based practice to their patients. In doing so, PCPs 
can develop effective educational strategies for their patients and ultimately improve patient 
outcomes. Specifically, NPs can educate their patients with diabetes and depression that 
depression is a manageable condition, as is diabetes. Further, information can be provided on the 
sequelae of untreated/poorly-controlled depression and its negative impact on diabetes self-care 
activities (Bell et al. , 2010; Dirmaier et al. , 2010; Egede et al. , 2009; Lin et al., 2004). 
Additionally, patient education level needs to be taken into consideration when developing a plan 
of care for this population (Lamers et al. , 2011 ). As such, the PCP can tailor the plan of care to 
the patient's understanding of their condition/s. 
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Conclusion 
Diabetes is a global threat, with no promise of slowing down. The aim of this integrative 
literature review was to answer the question: How can the NP promote self-care for the patient 
with diabetes and depression? A comprehensive literature review was undertaken and resulted in 
18 studies pertaining to this question. The analysis of the literature demonstrates the association 
of diabetes and depression, specifically the negative impact on diabetes self-care activities. 
Furthermore, analysis of the literature reveals that gaps exist in identifying diabetic patients with 
depression in clinical practice, prescribing optimal antidepressant agents, patient adherence to 
healthy eating and exercise, and PCPs following clinical guidelines. However, the review of the 
literature showed significant promise with the use of the TEAMcare collaborative model for 
improved patient outcomes for patients with diabetes and depression. 
A significant proportion of the available literature discusses the relationship between 
diabetes and depression. Researchers and patients alike have described this phenomenon as the 
"chicken and egg thing". Regardless of which conditions came first, research has shown an 
undisputable association between poor self-care and depression among patients with diabetes. 
NPs have provided primary care services to British Columbians for over a decade and have 
demonstrated that they are competent primary care providers. NPs caring for patients with 
diabetes and depression have the onus to screen for new/on-going depressive symptoms, provide 
evidence-based treatments, support and educate their patients, and explore the role of the NP in 
the collaborative care model. Further research is required to determine the uptake and screening 
practices of depression in primary care, the utilization of the collaborative model for multiple 
chronic conditions and a further need to examine the delivery of healthcare by NPs for patients 
with multiple chronic conditions. Optimizing the delivery of care to this vulnerable population 
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has the potential to improve patient outcomes and the uptake of self-care practices. Furthermore, 
through such initiatives this could impact the delivery of care for others with multiple chronic 
conditions, thus potentially impacting upon the provision of wider healthcare services and 
economic costs. 
64 
References 
Ades, P. A., Keteyian, S. J. , Balady, G. J. , Houstan-Miller, N., Kitzman, D. W., Mancini, D. M., 
& Rich, M. W. (2013). Cardiac rehabilitation exercise and self-care for chronic heart 
failure . JACC: Heart Failure, 1(6), 540-547. doi: http://dx.doi.org/10.1016/j.jchf.2013 .09 
.002 
Ali, S., Stone, M. A., Peters, J. L. , Davies, M. J., & Khunti, K. (2006). The prevalence of co-
morbid depression in adults with type 2 diabetes: A systematic review and meta-analysis. 
Diabetic Medicine, 23(11 ), 1165-1173. doi: 10.1111 /j.1464-5491.2006.01943 .x 
American Diabetes Association. (2015). Standards of Medical Care in Diabetes. Retrieved from 
http:// care.diabetesj oumals. org/ content/3 9/Supplement_ 1 
American Psychiatric Association. (2013) . Diagnostic and statistical manual of mental disorder 
(5th ed.). Arlington, VA: American Psychiatric Association. 
Anderson, R. J., Clouse, R, E., Freedland, K. E., & Lustman, P. J. (2001). The prevalence of 
comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care, 24(6), 
1069-1078. Retrieved from http://care.diabetesjoumals.org/ 
Arroll, B., Goodyear-Smith, F., Crengle, C., Gunn, J., Kerse, N., Fishman, T., . . . Hatcher, S. 
(2010). Annals of Family Medicine, 8(4), 348-353. doi: 10.1370/afm.1139 
Bailer, J., Witthoft, M., Wagner, H., Mier, D. , Diener, C., & Rist, F. (2014). Childhood 
maltreatment is associated with depression but not with hypochondriasis in later life. 
Journal of Psychosomatic Research, 77(2), 104-108. doi: 10.1016/j .jpsychores 
.2014.06.004 
Bayliss, E. A., Edwards, A. E., Steiner, J. F., & Main, D. S. (2008). Processes of care desired by 
elderly patients with multimorbidities. Fam Pract, 25(4), 287-293 . doi:10.1093 /fampra 
/cmn040 
Bell, R. A., Andrews, J. S., Arcury, T. A., Snively, B. M. , Golden, S. L. , & Quandt, S. A. (2010). 
Depressive symptoms and diabetes self-management among rural older adults. American 
Journal of Health Behavior, 34(1 ), 36-44. Retrieved from http://www.ncbi.nlm.nih.gov 
/pmc/articles/PMC2726973/ 
BCGuidelines. (2015). Diabetes care. Retrieved from http://www2.gov.bc.ca/gov/content/hea1th 
/practitioner-professional-resources/be-guidelines/diabetes 
BCGuidleines. (2013). Major depressive disorder in adults: Diagnosis and management. 
Retrieved from http://www2.gov.bc.ca/gov/content/health/practitioner-professional-
resources/bc-guidelines/depression-in-adults 
Bogner, H. R., Morales, K. H., Post, E. P., & Bruce, M. L. (2007). Diabetes, depression, and 
death: a randomized controlled trial of a depression treatment program for older adults 
based in primary care (PROSPECT). Diabetes Care, 30(12), 3005-3010. doi:10.2337 
/dc07-0974 
65 
Bogner, H. R., Morales, K. H., de Vries, H.F., & Cappola, A. R. (2012) . Integrated management 
of type 2 diabetes mellitus and depression treatment to improve medication adherence: a 
randomized controlled trial. Annals of Family Medicine, 10(1 ), 15-22. doi: 10.1370 
/afm.1344 
Bos-Touwen, I., Schuurmans, M., Manninkhof, E. M., Kopershoek, Y. , Spruit-Bentvelzen, L., 
Erugrul-van der Graff, I. , . .. Trappenburg, J. (2015). Patient and disease characteristics 
associated with activation of self-management in patients with diabetes, chronic 
obstructive pulmonary disease, chronic heart failure and chronic renal disease: A cross-
sectional survey study. PLOS ONE, 10(5), 1-15. doi:10.1371/journal.pone.012640 
Canadian Diabetes Association. (2009). An economic tsunami: The cost of diabetes in Canada. 
Retrieved from http://www.diabetes.ca/publications-newsletters/advocacy 
-reports/economic-tsunami-the-cost-o f-dia betes-in-canada 
Canadian Diabetes Association. (2013). Clinical practice guidelines: Full guidelines. Retrieved 
from http://guidelines.diabetes.ca/fullguidelines 
Canadian Diabetes Association. (2015). Types of Diabetes. Retrieved from http ://www 
.diabetes.ca/about-diabetes/types-of-diabetes 
Canadian Nurses Association. (2002). Supporting self-care: A shared initiative 1999-2002. 
Retrieved from http://www.hc-sc.gc.ca/hcs-sss/alt_formats/hpb-dgps/pdf/pubs/2002-
selfauto-collabor/2002-selfauto-collabor-eng.pdf 
Canadian Nurses Association. (2010). Canadian nurse practitioner: Core competency 
framework. Retrieved from http://www.cno.org/Global/for/mec/pdf 
/CompetencyFramework_ en.pdf 
Canadian Task Force on Preventive Health Care. (2013). Screening for depression. Retrieved 
from http://canadiantaskforce.ca/ ctfphc-guidelines/2013-depression/ 
Cole, J. A., Smith, S. M., Hart, N., & Cupples, M. E. (2011). Systematic review of the effect of 
diet and exercise lifestyle interventions in the secondary prevention of coronary heart 
disease. Cardiology Research and Practice, 2011, 232351. doi: 10.4061/2011/232351 
College of Registered Nurses of British Columbia. (2015a). Applying the Competencies Required 
for Nurse Practitioners in British Columbia. Retrieved from https://cmbc.ca/Registration 
/Lists/RegistrationResources/440PLAR.pdf 
66 
College of Registered Nurses of British Columbia. (2015b ). Nurse p ractitioner. Retrieved from 
https://cmbc.ca/WhatNursesDo/TypesOfNurses/Pages/NursePractitioner.aspx 
Ciechanowski, P. (2011). Diapression: An integrated model for understanding the experience of 
individuals with co-occurring diabetes and depression. Clinical Diabetes, 29(2), 43-49. 
doi: 10.233 7 /diaclin.29.2.43 
Critical Appraisal Skills Programme. (2013). CASP Checklists. Retrieved from http://www.casp-
uk.net/# ! casp-tools-checklists/ c 18f8 
Dirmaier, J., Watzke, B., Koch, U., Schulz, H., Lehnert, H. , Pieper, L., & Wittchen, H. U. 
(2010). Diabetes in primary care: prospective associations between depression, 
nonadherence and glycemic control. Psychotherapy & Psychosomatics, 79(3 ), 172-178. 
doi :10.1159/000296135 
Dufton, J. A., Li, W. W ., & Koohoom, M. (2007). A comparison of diabetic complications and 
health care utilization in diabetic patients with and without comorbid depression. BC 
Medical Journal, 49(8), 436-440. Retrieved from http://www.bcmj.org/ 
Egede, L. E., Ellis, C., & Grubaugh, A. L. (2009). The effect of depression on self-care 
behaviors and quality of care in a national sample of adults with diabetes. General 
Hospital Psychiatry, 31(5), 422-427. doi: 10.1016/j.genhosppsych.2009.06.007 
Egede, L, E., Grubaugh, A. L. , & Ellis, C. (2010). The effect of major depression on preventive 
care among adults with diabetes. General Hospital Psychiatry, 32(6), 563-569. doi : 10 
.1016/j .genhosppsych.2010.08.002 
Egede, L. E., & Ellis, C. (2010). Diabetes and depression: Global perspectives. Diabetes 
Research and Clinical Practice, 87(3), 302-312. doi: 10.1016/j .diabres.2010.01.024 
Ekoe, J., Punthakee, Z., Ransom, T., Prebtani, A. P.H., & Goldberg, R. (2013). Clinical practice 
guidelines: Screening for type 1 and type 2 diabetes. Canadian Journal of Diabetes, 
37(S 1 ), S 12-S 15. doi: http://dx.doi.org/10.1016/j/jcjd.2013.01.012 
Fowler, M. J. (2008). Micorvascular and macrovascular complications of diabetes . Clinical 
Diabetes, 26(2), 77-82. doi: 10.233 7 /diaclin.26.2. 77 
Gask, L. , Ludman, E., & Schaefer, J. (2006) . Qualitative study of an intervention for depression 
among patients with diabetes: How can we optimize patient-professional interaction? 
Chronic Illness, 2(3), 231-242. doi: 10.1179/174592006x129509 
Goldenberg, R., & Punthakee, Z. (2013). Clinical practice guidelines: Definition, classification 
and diagnosis of diabetes, prediabetes and metabolic syndrome. Canadian Journal of 
Diabetes, 37(Sl), S8-Sll. doi : http://dx.doi.org/10.1016/j.jcjd.2013.01.011 
67 
Gonzalez, J. S., Peyrot, M., McCarl, L.A., Collins, E. M., Serpa, L., Mimiaga, M. J., & Safren, 
S. A. (2008). Depression and diabetes treatment nonadherence: A meta-analysis. 
Diabetes Care, 31(12), 2398-2403. doi: 10.2337/dc08-1341 
Harper, W., Clement, M., Goldenberg, R., Hanna, A., Main, A., Retnakaran, R., ... Yale, JF. 
(2013). Clinical practice guidelines: Pharmacological management of type 2 diabetes. 
Canadian Journal of Diabetes, 37(Sl), S61-S68. doi: http://dx.doi.org/10.1016/j.jcjd 
.2013.01.021 
Horrocks, S., Anderson, E., & Salisbury, C. (2002). Systematic review of whether nurse 
practitioners working in primary care can provide equivalent care to doctors. British 
Medical Journal, 324(7341), 819-823. Retrieved from http://www.jstor.org/stable 
/25227930 
International Diabetes Federation. (2012). Clinical guidelines task force : Global guideline for 
type 2 diabetes. Retrieved from http://www.idf.org/sites/default/files/IDF-Guideline-for 
-Type-2-Diabetes.pdf 
International Diabetes Federation. (2014). Key .findings 2014. Retrieved from http://www.idf 
. org/ diabetesatlas/update-2014 
Johnson, J. A., Al Sayah, F., Wozniak, L., Rees, S., Soprovich, A., Qiu, W., ... Majumdar, S. R. 
(2014). Collaborative care versus screening and follow-up for patients with diabetes and 
depressive symptoms: results of a primary care-based comparative effectiveness trial. 
Diabetes Care, 37(12), 3220-3226. doi:10.2337/dc14-1308 
Jones, R. E., Brashers, V. L., & Huether, S. E. Alterations of hormonal regulation. In K. 
McCance, S. Huether, V. Brashers, & N. Rote (Eds.), Pathophysiology: The biologic 
basis for disease in adults and children (pp. 727-780). Maryland Heights, MO: Mosby. 
Katon, W.J., Rutter, C., Simon, G., Lin, E. H.B., Ludman., Ciechanowski, P., ... Von Korff., M. 
(2005). The association of comorbid depression with mortality in patients with type 2 
diabetes. Diabetes Care, 28(11), 2668-2672. Retrieved from http://care.diabetesjoumals 
.org/ 
Katon, W. J., Lin, E. H., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., ... 
McCulloch, D. (2010). Collaborative care for patients with depression and chronic 
illnesses. New England Journal of Medicine, 363(27), 2611-2620. doi:10.1056 
/NEJMoa1003955 
Kroenke, K., Spitzer, R. L., & Williams, J.B. W. (2001). The PHQ-9: Validity of a brief 
depressive severity measure. Journal of General Internal Medicine, 16(9), 606-613. 
Retrieved from http://www.jgim.org/ 
Kuo, YF., Chen, NW., Baillargeon, J., Raji, M.A., & Goodwin, J. S. (2015). Potentially 
preventable hospitalizations in Medicare patients with diabetes: A comparison of primary 
care provided by nurse practitioners versus physicians. Medical Care, 53(9), 776-783. 
doi: 10.1097 /MLR.0000000000000406 
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., ... 
Ravindran, A. V. (2009). Journal of Affective Disorders, 117, S26-S43 . doi: 10.1016 
/j.jad.2009 .06.041 
68 
Lamers, F., Jonkers, C. C., Bosma, H., Knottnerus, J. A., & van Eijk, J. T. (2011). Treating 
depression in diabetes patients: does a nurse-administered minimal psychological 
intervention affect diabetes-specific quality of life and glycaemic control? A randomized 
controlled trial. J Adv Nurs, 67(4), 788-799. doi:10.1111/j.1365-2648.2010.05540.x 
La Vance, M. S., Fairchild, R., & Rosado, R. J. (2015). Turning the table: Depression screening 
as the 6th vital sign. The Journal for the Nurse Practitioner, 11 (2), 199-206. doi: 
http://dx.doi.Org/10.1016/j.nurpra.2014.10.026 
Lin, E. H.B., Katon, W., Von Korff, M., Rutter, C. , Simon, Oliver, M., ... Young, B. (2004). 
Relationship of depression and diabetes self-care, medication adherence, and preventive 
care. Diabetes Care, 2 7(9), 2154-2160. Retrieved from http://www.ncbi.nlm.nih.gov 
/pubmed/153334 77 
Lin, E. H.B., Katon, W., Rutter, C., Simon, G, E., Ludman, E. J., Von Korff, M., ... Walker, E. 
(2006). Effects of enhanced depression treatment on diabetes self-care. Annals of Family 
Medicine, 4(1), 46-53. doi: 10.1370/afm.423 
Lin, E. H.B., Von Korff, M. , Ciechanowski, P., Peterson, D., Ludman., E. J., Rutter, C. M., ... 
Katon, W. J. (2012). Treatment adjustment and medication adherence for complex 
patients with diabetes, heart disease and depression: A randomized control trial. Annals of 
Family Medicine, 10(1), 6-14. doi: 10.1270/afm.1343 
Lin, E. H., Von Korff, M., Peterson, D., Ludman, E. J., Ciechanowski, P., & Katon, W. (2014). 
Population targeting and durability of multimorbidity collaborative care management. 
American Journal of Managed Care, 20(11 ), 887-895. Retrieved from http://www.ncbi 
.nlm.nih.gov /pubmed /25495109 
Lossnitzer, N. N ., Herzog, W., Stork, S., Wild, B., Muller-Tasch, T. , Lehrnhuhl, E., ... 
Angermann, C. E. (2013). Incidence rates and predictors of major and minor depression 
in patients with heart failure. International Journal of Cardiology, 167(2), 502-507. 
doi: 10.1016/j .ijcard.2012.01.062 
McGibbon, A., Richardson, C., Hernandez, C., & Dornan, J. (2013). Clinical practice guidelines: 
Pharmacotherapy in type 1 diabetes. Canadian Journal of Diabetes, 3 7(S 1 ), S56-S60. 
doi:http://dx.doi.org/ 10.1016/j.jcjd.2013.01.020 
McSharry, J., Bishop, F. L., Moss-Morris, R., & Kendrick, T. (2013). 'The chicken and egg 
thing' : Cognitive representations and self-management of multimorbidity in people with 
diabetes and depression. Psychology & Health, 28(1), 103-119. doi: 10.1080/08870446 
.2012.716438 
Meeuwissen, J., Holleman, G., de Jong, F., Nuyen, J., & van der Feltz-Comelis, C. (2011) . 
Screening and guided self-help intervention for anxiety and depression in patients with 
type 2 diabetes. European Diabetes Nursing, 8(2), 4 7-52a. doi: 10.1002/edn.17 
National Institute of Mental Health. (n.d.). Chronic illness and mental health. Retrieved from 
http://www.nimh.nih.gov/health/publications/chronic-illness-mental-health-
2015/index.shtml 
Parikh, S. V., Segal, Z. V., Grigoriadis, S., Ravindran, A. V., Kennedy, S. H., Lam, R. W., & 
Patten, S. B. (2009). Canadian network for mood and anxiety treatments (CANMAT) 
clinical guidelines for the management of major depressive disorder in adults. II. 
Psychotherapy alone or in combination with antidepressant medication. Journal of 
Affective Disorders, 117, S15-S25. doi: 10.1016/j.jad.2009.06.042 
69 
Pearce, M. J., Pereira, K., & Davis, E. (2013). The psychological impact of diabetes: A practical 
guide for the nurse practitioner. Journal of the American Association of Nurse 
Practitioner, 25(11), 578-583. doi: 10.1002/2327-6924.12035 
Poirier, P., Dufour, R., Capentier, A., & Larose, E. (2013). Clinical practice guidelines: 
Screening for the presence of coronary artery disease. Canadian Journal of Diabetes, 
37(Sl ), S 105-S 109. doi: http://dx.doi.org/10.1016/j.jcjd.2013.01.031 
Public Heath Agency of Canada. (2011). Diabetes in Canada: Facts andfiguresfrom a public 
health perspective. Ottawa, ON: Public Health Agency of Canada. 
Reeves, L. M., Hermens, R., Braspenning, J., Grol, R., & Sibbald, B. (2005). Substitution of 
doctors by nurses in primary care. Cochrane Database of Systematic Reviews 2005(2), 1-
43. doi: 10.1002/14651858.CD001271.pub2. 
Richardson, G. C., Derouin, A. L., Vorderstrasse, A. A., Hipken, J., & Thompson, J. A. (2014). 
Nurse practitioner management of type 2 diabetes. The Permanente Journal, 18(2), e 134-
el 40. doi: http://dx.doi.org/10.7812/TPP/13-108 
Rutledge, T., Reis, V. A., Linke, S. E., Greenberg, B. H., & Mills, P. J. (2006). Depression in 
heart failure: A meta-analytic review of prevalence, intervention effects, and associations 
with clinical outcomes. Journal of the American College of Cardiology, 48(8), 1527-
1537. doi: 10.1016/j.jacc.2006.06.055 
Schneider, C., Jick, S.S., Bothner, U., & Meier, C.R. (2010). COPD and the risk of depression. 
CHEST, 137(2), 341-347. doi: 10.1378/chest.09-0614 
70 
Siguroardottir, A. K. (2005). Self-care in diabetes: Model of factors affecting self-care. Journal 
of Clinical Nursing, 14(3), 301-314. Retrieved from http://www.ncbi .nlm.nih.gov 
/pubmed/15707440 
Statistics Canada. (2014). Age-standardized mortality rates by selected causes, by sex (Both 
sexes). Retrieved from http://www. statcan. gc.ca/tables-tableaux/ sum-
som/101 I cstO 1 /health3 Oa-eng.htm 
Statistics Canada. (2015). Diabetes, by sex, provinces and territories (Number by person). 
Retrieved from http://www.statcan.gc.ca/tables-tableaux/sum-som/l01 /cst01/health54a-
eng.htm 
Sumlin, L. L., Garcia, T. J., Brown, S., A., Winter. M., A., Garcia, A. A., Brown, A., & Cuevas, 
H., E. (2014). Depression and adherence to lifestyle changes in type 2 diabetes: A 
systematic review. The Diabetes Educator, 40(6), 731-744. doi: 10.1177 
/0145721714538925 
Thombs, B. D., Bass, E. B. , Ford, D. E. , Stewart, K. J. , Tsilidis, K. K. , Patel, U., & ... 
Ziegelstein, R. C. (2006). Prevalence of depression in survivors of acute myocardial 
infarction. Journal Of General Internal Medicine, 21(1), 30-38. doi : 10.1111/j.1525 
-1497.2005.00269.x 
United States Preventive Services Task Force. (2016). Depression in adults: Screening. 
Retrieved from http://www. uspreventiveservicestaskforce. org/Page/Document 
/UpdateSummary Final/ depression-in-adults-screening 1 ?ds= 1 &s=depression 
Whittemore, R., & Knalf, K. (2005). The integrative review: Updated methodology. Journal of 
Advanced Nursing, 52(5), 546-553. Retrieved from http://www.ncbi.nlm.nih.gov 
/pubmed/16268861 
Whiting, M., Scammell, A. , Gray, J., Schepers, A. K., & Bifulco, A. (2006). Managing type 2 
diabetes and depression in primary care. Primary Care Mental Health, 4(3), 175-184. 
Retrieved from http:/ !proxy .library .unbc.ca:2048/login?url=http://search.ebscohost.com 
/login. aspx ?direct=true&db=ccm&AN =20097123 l 8&login.asp&site=ebost-
live&scope=site 
World Health Organization. (2015). JO facts about diabetes. Retrieved from http: //www 
. who. int /features/factfiles/ diabetes/facts/ en/ 
71 
Appendix A 
Screening Recommendations by Guideline 
American Diabetes Association (2015) 
Type ,of Screetiing 
,, 
,Reco.rfup.endatiori 't 0 fr "" #k @; 
''' ' 04,' ' 
Recommended Screening Consider screening for T2DM in adults who are overweight or 
for Diabetes obese, and have one or more additional risk factors for diabetes, 
and should start at age 45 
If tests normal, repeat testing every 3 years 
Glycemic Control (Al C) A1C:S7% 
Every 3 months if treatment change or not meeting glycemic goals 
Every 6 months if meeting treatment goals and stable glycemic 
control 
Consider <6.5% for some T2DM, long life expectancy or no 
cardiovascular disease 
Consider <8% for patients with severe hypoglycemia, limited life 
expectancy, advance complications, comorbid conditions 
Blood Pressure < 140/90 mmHg 
Consider <130/80 mmHg for younger patients and if can be 
achieved without undue treatment burden 
Measure BP at every routine visit 
Eye Screening TlDM: 
5 years after diagnosis and rescreen annually 
T2DM: 
At diagnosis and rescreen every 1-2 years 
Kidney Screening At diagnosis of DM and rescreen annually 
Check for random urine ACR, serum creatinine for eGFR 
Dyslipidemia In adults not taking statins, it is reasonable to obtain a lipid profile 
at the time of diabetes diagnosis, at an initial medical evaluation, 
and every 5 years thereafter, or more frequently if indicated 
Foot Care Annually by health care provider 
Immunizations Provide routine vaccinations for children and adults with diabetes 
as for the general public 
For patients > 2 years of age, administer pneumococcal 
72 
polysaccharide vaccine 23 (PPSV23) 
Adults 2: 65 years of age, administer pneumococcal conjugate 
vaccine 13 (PCV13) 
Annual influenza vaccine 
Neuropathy TlDM: 
Annual screening should commence after 5 years duration of 
diabetes 
T2DM: 
Screen at diagnosis and annually thereafter 
Screen using a 10-g mono filament and at least one of the 
following: pinprick, temperature, or vibration sensation 
Mental Health Routinely screen for depression, diabetes-related distress, anxiety, 
eating disorders and cognitive impairment 
Patients with diabetes and depression should receive stepwise 
collaborative care for the management of depression 
BCGuidelines (2015) 
Type of Screening Recommendation 
Recommended Screening Every 3 years in individuals 2:40 years of age or in individuals at 
for Diabetes high risk 
Screen earlier and/or more frequently in people with additional 
risk factors for diabetes 
Glycemic Control (AlC) A1C~7% 
Every 3 months 
Consider every 6 months if treatment and lifestyle stable 
Blood Pressure ~140/90 mmHg 
Check at diagnosis and regularly thereafter 
Eye Screening TlDM: 
5 years after diagnosis and rescreen annually, then every 1-2 years 
T2DM: 
At diagnosis and rescreen every 1-2 years 
Kidney Screening Annually 
Check for ACR and serum creatinine for eGFR 
Dyslipidemia Fasting lipid profile at diagnosis and ever 1-5 years for 
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reassessment 
Foot Care Annually by health care provider and more frequently for those at 
high risk 
Encourage regular self-exam of feet 
Immunizations Annual influenza vaccine 
Pneumococcal vaccine is recommended 
Neuropathy Check annually using a 10-g monofilament or 128-Hz tuning fork 
during foot exam 
Mental Health Advise screening for depression, anxiety and eating disorders 
Canadian Diabetes Association (2013) 
Type of Screening Recommendation 
Recommended Screening Every 3 years in individuals 2:40 years of age or in individuals at 
for Diabetes high risk using a risk calculator 
Screen earlier and/or more frequently in people with additional 
risk factors for diabetes or those at very high risk using a risk 
calculator 
Glycemic Control (AlC) A1C~7% 
AlC every 3 months when glycemic targets are not being met and 
with treatment adjustment 
Consider AlC ~6.5% for some with T2DM to reduce nephropathy 
or retinopathy but consider risk of hypoglycemia 
Consider AlC 7.1-8.5% if: limited life expectancy, multiple 
comorbidities, history of severe hypoglycemia or hypoglycemia 
unawareness 
Blood Pressure <130/80 mmHg 
Eye Screening TlDM: 
5 years after diagnosis and rescreen annually 
T2DM: 
At diagnosis and rescreen every 1-2 years 
Kidney Screening At diagnosis of DM and rescreen annually 
Check for random urine ACR, serum creatinine for eGFR 
Dyslipidemia Fasting (8-hour fast) lipid profile (TC, HDL-C, TG, and calculated 
LDL-C) or nonfasting lipid profile (apo B, non-HDL-C 
calculation) should be measured at the time of diagnosis of 
diabetes 
Foot Care Annually by health care provider and more frequently for those at 
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high risk 
Immunizations Annual influenza vaccine 
Pneumococcal vaccine is recommended 
Neuropathy TlDM: 
Annual screening should commence after 5 years' postpubertal 
duration of diabetes 
T2DM: 
Screen at diagnosis and annually thereafter 
Screen using a 10-g mono filament or loss of sensitivity to 
vibration at the dorsum of the great toe 
Mental Health Regularly screen for depressive and anxious symptoms 
International Diabetes Federation (2012) 
(T2DM only) 
l'ype ofScreening m '1~~ Recommendation "'' w ·"' 'i' ' •'!%· 
Recommended Screening High risk individuals should be screened. 
for Diabetes 
Rescreen every 3-5 years 
Glycemic Control (Al C) A1C<7% 
Frequency 
Every 2-6 months depending on level, stability of blood glucose 
control and changes in theraov 
Blood Pressure ~130/80 mmHg 
Annually, if known CVD measure with each clinical visit 
Eye Screening At DM diagnosis 
Routinely every 1-2 years 
Kidney Screening At DM diagnosis and annually 
Check for albuminuria, creatinine, and eGFR 
Dyslipidemia Serum lipids at diagnosis and annually thereafter 
Foot Care Annually by health care provider 
Immunizations NIA 
Neuropathy Diagnose sensorimotor nerve damage by history and examination 
(monofilament with or without temperature, non-traumatic pin-
prick, vibration [tuning fork], ankle reflexes), and/or simple 
quantitative testing ( e.g. biothesiometer vibration perception) 
Mental Health Assess periodically using a well validated tool 
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Appendix B 
The Patient Health Questionnaire (PHQ-9) 
over the last 2 weeks, how often have you been,. Not at all Several More "' H Nearly 
bothered by any of the .following problems? * 5k days than half every 
. "' "' w ' the days 
day 
1. Little interest or pleasure in doing things 0 1 2 3 
2. Feeling down, depressed, or hopeless 0 1 2 3 
3. Trouble falling or staying asleep, or sleeping 0 1 2 3 
too much 
4. Feeling tired or having little energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself-or that you are a 0 1 2 3 
failure or have let yourself or your family down 
7. Trouble concentrating on things, such as 0 1 2 3 
reading the newspaper or watching television 
8. Moving or speaking so slowly that other people 0 1 2 3 
could have noticed? Or the opposite-being so 
fidgety or restless that you have been moving 
around a lot more than usual 
9. Thoughts that you would be better off dead or 0 1 2 3 
of hurting yourself in some way 
For office coding + + + 
=Total Score: 
If you checked off any problems, how difficult have these problems made it for you to do 
your work, take care of things at home, or get along with other people? 
Not ditlicuU 
at all 
Somewhat 
difficult 
Very 
difficult 
Extremely 
difficult 
Developed by Drs . Robert L. Splitzer, Janet B.W . Williams, Kurt Kroenke and colleagues, with 
an educational grant from Pfizer Inc . No permission required to reproduce, translate, display or 
distribute. 
Database search n = 185 
Duplicates n = 14 
Appendix C 
Literature Search Strategy Flowchart 
Number of records screened for title and abstract n = 171 
Excluded n = 130 
Included n = 41 
Hand search of reference lists n = 17 
Excluded n = 11 
Included n = 6 
Number of full text records assessed for eligibility n = 4 7 
Number of studies included in review n = 18 
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Appendix D 
Summary of Recommendations 
Clinical Practice Screen for depressive symptoms at the diagnosis of diabetes, patients with 
poorly controlled diabetes and at each follow-up visit. 
Be current on evidence-based treatments for depression and 
prescribe/titrate antidepressants appropriately. 
Support the patient by providing non-pharmacological therapies such as 
CBT. 
For patients unresponsive to pharmacological and non-pharmacological 
therapies, referral is warranted. 
Integrate the collaborative care model into practice. 
Monitor the implementation of clinical guidelines and the outcomes of 
patient care, including the collection of population and practice-specific 
data to track outcomes. 
Research Further research at the primary care level to determine the uptake and 
screening practices of depression by PCPs. 
Future trials investigating the use of the collaborative care model in the 
context of other chronic conditions. 
Future trials to examine NP healthcare delivery for patients with chronic 
conditions in BC. 
Education Be current on evidence-based practice. 
NPs can educate their depressed diabetic patients on the sequelae of 
untreated/poorly-controlled depression and its negative impact on self-care 
activities. 
NP can support their patient by educating the patient about depression and 
that is a manageable condition, as is their diabetes . 
